Thyrotoxicosis

THYROTOXICOSIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints E4_THYTOXGOITDIF E4_THYTOXNOD E4_THYTOXGOITMULT E4_THYTOXECT E4_THYTOXFAC E4_THYCRISIS E4_THYTOXNAS	13445
6. Filter based on genotype QC (FinnGen only)	12164

Control definitions (FinnGen only)

Control exclude: THYROID_DISORDER_IBD

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	THYROTOXICOSIS
CONTROL_EXCLUDE	THYROID_DISORDER_IBD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_THYTOXGOITDIF\|E4_THYTOXNOD\|E4_THYTOXGOITMULT\|E4_THYTOXECT\|E4_THYTOXFAC\|E4_THYCRISIS\|E4_THYTOXNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Thyrotoxicosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	77269	61676	14979
Only index persons	67659	54737	12922
Unadjusted period prevalence (%)
Whole population	1.50	1.77	0.42
Only index persons	1.72	2.01	0.49
Median age at first event (years)
Whole population	54.48	53.92	57.07
Only index persons	52.97	52.26	55.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12164	9621	2543
Unadjusted period prevalence (%)	2.95	3.42	1.17
Median age at first event (years)	53.74	51.88	60.75

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12606: Matched controls
126060

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

7.4

323.3

477

666

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

30.8

310.4

203

E03.89

ICD-10 Finland

Other specified hypothyroidism

4.5

307.7

1125

2708

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

42.5

307.7

982

250

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

170.5

307.7

1342

H03AA01

ATC

levothyroxine sodium; systemic

7.8

307.7

7717

21260

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

22.0

307.7

1480

756

BAA60

NOMESCO Finland

Total thyroidectomy

22.3

307.7

1944

1024

C01BD01

ATC

amiodarone; systemic

6.5

307.7

683

1102

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

217.6

307.7

1377

24210

ICD-8 Finland

Thyrotoxicosis with or without goitre, Toxic nodular goitre

+∞

307.7

326

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.7

307.7

1310

3828

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

1921.6

307.7

5693

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

52.1

307.7

452

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

192.0

307.7

1550

H03BB01

ATC

carbimazole; oral

1647.3

307.7

9044

194

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

+∞

307.7

860

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

1070.8

307.7

2135

T86

ICPC

Hypothyroidism/myxoedema

4.0

307.7

1229

3298

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

11671.8

307.7

6361

E05.1

ICD-10 Finland

Thyrotoxicosis with toxic single thyroid nodule

1086.3

307.7

318

C07AA05

ATC

propranolol; systemic

3.4

307.7

4406

17198

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

15.0

307.7

999

719

E05.89

ICD-10 Finland

Other thyrotoxicosis

991.8

307.7

569

104

Kela drug reimbursment

Thyroid insufficiency

7.5

307.7

2938

4933

T85

ICPC

Hyperthyroidism/thyrotoxicosis

43.1

307.7

620

151

C07AB07

ATC

bisoprolol; oral

2.3

307.7

6913

43876

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

3.1

307.7

3055

11666

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

91.0

275.0

144

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

20.5

265.8

202

100

E06.3

ICD-10 Finland

Autoimmune thyroiditis

15.3

261.5

229

152

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

3.7

259.7

875

2494

E03

ICD-10 Finland

Other hypothyroidism

3.0

259.3

1297

4708

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

5.8

234.2

435

769

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

15.0

234.0

207

140

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

1160.0

233.9

228

H062, E050,

ICD-10 Finland

+∞

226.7

217

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.6

207.5

707

2025

E06.9

ICD-10 Finland

Thyroiditis, unspecified

28.6

203.3

136

24209

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffuse NUD

+∞

201.6

193

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

191.5

4940

33770

2420A

ICD-9 Finland

Thyrotoxicosis with or without goitre, Toxic diffuse goitre

+∞

182.7

175

H05.2

ICD-10 Finland

Exophthalmic conditions

17.5

171.3

140

H03BA02

ATC

propylthiouracil; oral

+∞

166.0

159

TFP20

NOMESCO Finland

Cardiodefibrillation

2.7

164.3

943

3653

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

3.9

164.2

500

1323

24200

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi

+∞

157.6

151

E06.1

ICD-10 Finland

Subacute thyroiditis

+∞

156.6

150

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

28.7

145.2

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

143.9

2390

14126

24220

ICD-8 Finland

Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre

+∞

137.7

132

207

Kela drug reimbursment

Chronic arrhythmias

1.9

134.4

1890

10564

R94.6

ICD-10 Finland

Abnormal results of thyroid function studies

8.2

126.9

169

209

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

7.0

123.5

188

271

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

121.8

5766

44340

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

3.5

120.3

422

1228

C07AA07

ATC

sotalol; systemic

3.2

120.0

505

1645

A11CC03

ATC

alfacalcidol; systemic

3.8

118.3

374

1015

BAA25

NOMESCO Finland

Bilateral partial excision of thyroid gland

15.5

111.9

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

6.3

108.2

184

298

CA1AD

NOMESCO Finland

Orbita CT

15.7

106.8

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

105.7

1868

11149

106

Kela drug reimbursment

Hypoparathyroidism

9.3

100.0

120

130

E05.5

ICD-10 Finland

Thyroid crisis or storm

+∞

98.0

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

94.5

1680

10018

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

10.6

94.3

103

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

4.3

92.8

243

575

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.0

90.8

1069

5579

C07AB02

ATC

metoprolol; systemic

1.6

85.6

2287

15173

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

84.0

5501

44000

H02AB06

ATC

prednisolone; systemic

1.4

83.2

5777

46681

C01AA05

ATC

digoxin; systemic

2.1

78.8

849

4285

H50.6

ICD-10 Finland

Mechanical strabismus

40.1

78.8

E83.51

ICD-10 Finland

Hypocalcemia

5.7

78.1

145

256

TFP34

NOMESCO Finland

Electrophysiological investigation

2.8

77.7

406

1490

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

77.3

1493

9080

R00.2

ICD-10 Finland

Palpitations

1.9

77.2

1142

6418

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

3.4

76.7

275

811

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

76.7

2009

13227

B01AA03

ATC

warfarin; systemic

1.6

75.8

1878

12191

E06.4

ICD-10 Finland

Drug-induced thyroiditis

+∞

75.1

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

13.2

74.9

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

4.2

74.7

199

477

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

74.5

605

2732

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

4.5

73.3

180

405

C03CA01

ATC

furosemide; systemic

1.5

68.5

3249

24227

TFP35

NOMESCO Finland

Electroanatomical mapping

3.8

67.6

212

572

WX402

NOMESCO Finland

General anaesthesia

1.5

66.3

2686

19402

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

65.5

2509

17909

E06.2

ICD-10 Finland

Chronic thyroiditis with transient thyrotoxicosis

224.5

65.2

BA1AE, ,

SPAT

3.5

64.9

231

678

B01AF02

ATC

apixaban; oral

1.7

64.4

1475

9357

R06.0

ICD-10 Finland

Dyspnoea

1.4

64.3

3210

24116

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

63.6

2417

17215

I47.2

ICD-10 Finland

Ventricular tachycardia

3.2

63.2

251

789

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

61.2

678

3451

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

60.4

4057

32040

C01BC04

ATC

flecainide; systemic

2.4

57.8

423

1825

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

57.8

857

4805

2422A

ICD-9 Finland

Thyrotoxicosis with or without goitre, Toxic multinodular goitre

+∞

57.3

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

3.2

56.6

222

693

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.6

56.5

348

1387

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.1

55.9

520

2478

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

55.4

2464

18038

H50.2

ICD-10 Finland

Vertical strabismus

4.5

54.5

133

298

R53

ICD-10 Finland

Malaise and fatigue

1.4

54.4

3107

23783

H53.2

ICD-10 Finland

Diplopia

2.3

53.9

410

1800

C03DA01

ATC

spironolactone; oral

1.6

52.8

1334

8646

XF404

NOMESCO Finland

Ambulatory ECG

1.7

52.8

942

5576

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

52.5

461

2148

A02BC02

ATC

pantoprazole; systemic

1.3

52.4

8252

73626

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.2

52.2

430

1951

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

49.9

1534

10393

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

174.0

49.9

K78

ICPC

Atrial fibrillation/flutter

1.8

49.8

791

4524

E06.0

ICD-10 Finland

Acute thyroiditis

20.1

49.4

E07.89

ICD-10 Finland

Other specified disorders of thyroid

14.7

49.3

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

48.9

1574

10769

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.1

48.6

476

2313

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.0

48.4

537

2732

K04

ICPC

Palpitations/awareness of heart

1.8

48.1

695

3861

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

9.4

48.0

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

47.8

2030

14680

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.7

47.3

251

929

K80

ICPC

Cardiac arrhythmia NOS

1.6

46.7

1042

6543

A11CC02

ATC

dihydrotachysterol; oral

7.1

46.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

46.3

2791

21459

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

46.3

4234

34712

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

45.7

2081

15237

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

45.6

1521

10472

Z3231

NOMESCO Finland

Registered nurse

1.4

45.4

2947

22922

H03BB02

ATC

thiamazole; oral

120.5

44.8

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.4

44.3

308

1300

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

43.8

3252

25807

T89

ICPC

Diabetes insulin dependent

2.1

43.0

434

2134

H04AA01

ATC

glucagon; nasal, parenteral

2.6

42.8

257

1013

ZXE00

NOMESCO Finland

One hour or less

1.3

42.7

4344

36038

N02BE01

ATC

paracetamol; systemic, rectal

1.5

41.6

11002

103972

ZXA10

NOMESCO Finland

Bilateral

1.4

40.6

2025

15036

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

40.2

596

3335

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

2.6

39.1

237

938

E20.8

ICD-10 Finland

Other hypoparathyroidism

15.5

39.1

E05.81

ICD-10 Finland

Overproduction of thyroid-stimulating hormone

388.8

39.1

T81

ICPC

Goitre

4.7

38.8

190

I50.1

ICD-10 Finland

Left ventricular failure

2.0

38.3

432

2211

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

3.8

37.9

115

304

H02AB07

ATC

prednisone; oral

1.5

37.9

1485

10537

342

Kela drug reimbursment

Dronedarone

4.0

37.7

107

270

H50.8

ICD-10 Finland

Other specified strabismus

8.3

37.6

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.5

37.6

246

1010

I50.0

ICD-10 Finland

Congestive heart failure

1.7

36.6

694

4169

2423X

ICD-9 Finland

Thyrotoxicosis with or without goitre, Toxic nodular goitre, unspecified

+∞

36.5

C09DX04

ATC

valsartan and sacubitril; oral

3.9

36.4

107

277

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.8

36.0

111

297

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

2.8

35.8

180

649

A04

ICPC

Weakness/tiredness general

1.4

35.8

1849

13786

H02AB09

ATC

hydrocortisone; systemic

2.3

35.2

274

1216

O90.5

ICD-10 Finland

Postpartum thyroiditis

66.8

34.9

E05.3

ICD-10 Finland

Thyrotoxicosis from ectopic thyroid tissue

+∞

34.4

ZX120

NOMESCO Finland

Intravenous

1.5

34.0

977

6495

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

33.9

3501

28889

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.9

33.7

256

CAC44

NOMESCO Finland

Combined decompression of orbit

175.5

33.7

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

32.6

3035

24680

GB1AA

NOMESCO Finland

Tracheal X-ray examination

10.3

32.4

C01BD07

ATC

dronedarone; oral

4.0

32.1

221

A10AE04

ATC

insulin glargine; parenteral

1.5

32.0

908

6018

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

4.9

31.5

142

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

4.2

31.4

203

Z01.7

ICD-10 Finland

Laboratory examination

1.4

31.3

1891

14435

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

31.2

1128

7862

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

5.1

31.2

128

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.9

31.2

432

2368

CBK00

NOMESCO Finland

Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction

313.7

30.8

Z71.8

ICD-10 Finland

Other specified counselling

1.3

30.5

3969

33604

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

30.2

773

5002

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

29.4

1537

11450

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

29.3

4329

37147

A10AB04

ATC

insulin lispro; parenteral

2.0

29.2

313

1574

A10AC01

ATC

insulin (human); parenteral

1.6

29.2

713

4564

A10AB05

ATC

insulin aspart; parenteral

1.6

29.2

737

4756

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

28.8

912

6188

R03AC02

ATC

salbutamol; inhalant

1.2

28.7

6407

57456

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

4.0

28.6

196

A10AB01

ATC

insulin (human); parenteral

1.9

28.3

336

1752

AA1AD

NOMESCO Finland

CT of head and brain

1.3

27.6

2964

24457

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

27.6

2350

18821

WX892

NOMESCO Finland

Monitored bed care

1.6

27.5

714

4635

H3600, E103,

ICD-10 Finland

3.0

27.4

124

423

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.6

27.4

156

601

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

3.5

26.9

260

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

26.6

611

3854

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

26.5

4248

36669

A10AA01, ,

ATC

2.1

26.2

254

1231

G73.0*E05.9

ICD-10 Finland

Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]

+∞

26.0

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

3.4

25.9

276

CAC20

NOMESCO Finland

Lateral decompression of orbit

60.1

25.9

Z2221

NOMESCO Finland

Medical doctor

1.3

25.9

2939

24386

J01DB01

ATC

cefalexin; oral

1.3

25.8

9808

92552

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

25.8

1974

15561

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

25.8

8338

77277

BA1AN

NOMESCO Finland

Thyroid gland isotope imaging

261.2

25.7

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

25.4

754

5042

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.3

25.4

193

849

B01AB05

ATC

enoxaparin; parenteral

1.3

25.4

3403

28770

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

25.2

413

2383

SPAT1262

SPAT

Handing over of treatment supplies

1.3

25.1

1627

12516

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.1

25.1

248

1211

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

4.5

25.1

137

M14.5*E05.9

ICD-10 Finland

Arthropathy in thyrotoxicosis [hyperthyroidism]

+∞

25.0

E89.9

ICD-10 Finland

Postprocedural endocrine and metabolic disorder, unspecified

38.9

24.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

24.8

3182

26759

XCK00

NOMESCO Finland

Perimetry

1.6

24.5

639

4154

XF402

NOMESCO Finland

ECG with work load test

1.4

24.4

965

6834

N02AX02

ATC

tramadol; systemic, rectal

1.2

24.3

4607

40364

C09AA05

ATC

ramipril; oral

1.3

24.3

2277

18429

A10AE05

ATC

insulin detemir; parenteral

1.7

24.2

486

2965

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

8.8

24.1

AQ2

Electrophysiological electroanatomical examination

4.4

24.0

138

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.5

24.0

151

611

A10AE06

ATC

insulin degludec; parenteral

1.8

23.9

339

1872

K90.0

ICD-10 Finland

Coeliac disease

1.9

23.7

313

1691

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.1

23.6

161

A12AA04

ATC

calcium carbonate; oral

2.5

23.6

147

592

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

23.1

1930

15381

E05.8

ICD-10 Finland

Other thyrotoxicosis

+∞

22.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

22.9

987

7099

J01AA02

ATC

doxycycline; systemic

1.2

22.8

9108

85602

R11

ICD-10 Finland

Nausea and vomiting

1.4

22.7

953

6823

R03BB04

ATC

tiotropium bromide; inhalant

1.4

22.7

895

6335

R02

ICPC

Shortness of breath/dyspnoea

1.3

22.6

1452

11144

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

22.5

1701

13367

H02.5

ICD-10 Finland

Other disorders affecting eyelid function

5.2

22.4

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

22.0

1623

12705

2421A

ICD-9 Finland

Thyrotoxicosis with or without goitre, Toxic uninodular goitre

+∞

21.9

ZXD05

NOMESCO Finland

Urgent procedure

1.2

21.8

3079

26101

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.2

21.6

184

850

J01CA04

ATC

amoxicillin; systemic

1.2

21.5

9659

91515

A10AA02, ,

ATC

1.8

21.5

296

1622

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

21.4

2422

20018

R42

ICD-10 Finland

Dizziness and giddiness

1.3

21.4

2535

21064

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.1

21.4

193

912

GD1LA

NOMESCO Finland

2.4

21.4

139

572

A02BC01

ATC

omeprazole; systemic

1.2

21.3

2873

24222

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

21.2

2481

20580

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

21.2

4715

41797

CEC00

NOMESCO Finland

Recession of extraocular muscle

4.0

21.2

152

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

20.8

748

5199

SPAT1097

SPAT

Recording of ECG

1.3

20.7

1379

10636

H3601, E103,

ICD-10 Finland

2.9

20.7

317

N05CF01

ATC

zopiclone; oral

1.2

20.5

3408

29344

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

20.4

1553

12207

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.2

20.2

173

801

Z3226

NOMESCO Finland

Physiotherapist

1.3

20.2

1796

14404

24199

ICD-8 Finland

Non-toxic nodular goitre, Unspecified

2.6

20.2

116

450

CEW99

NOMESCO Finland

Other operation on extraocular muscle

8.4

20.1

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

20.1

604

4050

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.3

20.0

156

695

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.6

19.7

419

2593

SPAT1263

SPAT

Sampling

1.2

19.6

4509

40001

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

5.8

19.6

R4110

NOMESCO Finland

Physiotherapy

1.2

19.5

2878

24457

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

19.5

2469

20643

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

19.3

2976

25404

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

19.2

6466

59275

A02BC05

ATC

esomeprazole; systemic

1.2

19.2

4482

39796

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.4

19.2

132

558

1CX08, ,

NOMESCO Finland

4.5

19.1

103

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

7.5

19.1

N05BA04

ATC

oxazepam; oral

1.2

18.9

2892

24660

L28

ICPC

Limited function/disability (L)

1.3

18.4

1988

16312

R50.9

ICD-10 Finland

Fever, unspecified

1.3

18.4

1464

11566

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

21.7

18.1

C08CA01

ATC

amlodipine; oral

1.2

18.1

3825

33610

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

18.0

509

3368

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

18.0

1315

10268

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

17.9

6157

56403

E04.8

ICD-10 Finland

Other specified nontoxic goitre

3.6

17.9

162

A91

ICPC

Abnormal result investigation NOS

1.5

17.8

533

3571

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

17.6

2028

16752

J01DA01

ATC

[U] cefalexin

1.2

17.6

6916

64018

AR5

Catheter ablation of arrhythmia, target: atrial flutter

4.8

17.5

250, ,

Kela drug reimbursment

2.0

17.4

182

910

24400

ICD-8 Finland

Myxoedema, (hypothyreosis) post therapiam

15.6

17.4

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

17.4

1201

9301

R21

ICPC

Throat symptom/complaint

1.2

17.1

2293

19251

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

17.1

4728

42477

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

17.1

3147

27275

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

17.1

822

6023

M79.6

ICD-10 Finland

Pain in limb

1.2

17.1

5065

45771

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

4.0

16.9

118

I50

ICD-10 Finland

Heart failure

1.8

16.8

265

1514

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

2.7

16.8

332

E04

ICD-10 Finland

Other nontoxic goitre

3.5

16.8

164

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.7

16.6

316

1903

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

16.6

5729

52372

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

16.5

1975

16376

E89

ICD-10 Finland

Postprocedural endocrine and metabolic disorders, not elsewhere classified

170.2

16.5

EP1AE, ,

SPAT

1.8

16.4

261

1495

A99

ICPC

Disease/condition unspecnature/site

1.3

16.4

1073

8243

K02.1

ICD-10 Finland

Caries of dentine

1.2

16.4

6546

60511

A29

ICPC

General symptom/complaint other

1.3

16.3

1384

11014

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

16.3

2726

23392

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

2.2

16.3

131

593

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

16.3

256

1463

2429X

ICD-9 Finland

Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre or other cause

14.2

16.3

AQ1

Conventional electrophysiological examination

2.4

16.3

105

432

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

16.2

1404

11202

G47.3

ICD-10 Finland

Sleep apnoea

1.2

16.2

2097

17530

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.2

16.2

128

576

R51.80

ICD-10 Finland

Headache

1.3

16.1

1685

13755

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

16.1

5736

52507

K29.4

ICD-10 Finland

Chronic atrophic gastritis

1.9

16.1

200

1062

WZC30

NOMESCO Finland

Teaching

1.3

16.1

1621

13178

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

2.7

16.0

296

B81

ICPC

Anaemia vit B12/folate deficiency

1.6

15.8

346

2159

C08DB01

ATC

diltiazem; oral

1.5

15.8

425

2785

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

15.6

2174

18310

AN1

Coronary angiography

1.4

15.5

821

6109

J01FA10

ATC

azithromycin; systemic

1.2

15.4

6523

60430

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

15.4

511

3500

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

38.1

15.4

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

2.6

15.3

331

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

15.3

805

5985

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

15.3

4414

39692

R13

ICD-10 Finland

Dysphagia

1.4

15.3

672

4850

J01FF01

ATC

clindamycin; systemic

1.2

15.2

2740

23652

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

3.8

15.1

119

E50.0

ICD-10 Finland

Vitamin A deficiency with conjunctival xerosis

45.0

15.0

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.4

15.0

716

5237

A10BK03

ATC

empagliflozin; oral

1.3

14.9

894

6782

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.3

14.9

902

6852

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

14.9

536

3730

WX902

NOMESCO Finland

External defibrillation of heart

4.1

14.9

B01AF01

ATC

rivaroxaban; oral

1.3

14.8

1159

9123

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.4

14.8

592

4200

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

14.8

221

1245

I49.5

ICD-10 Finland

Sick sinus syndrome

1.6

14.8

331

2079

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

13.2

14.6

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

14.6

3953

35325

A98

ICPC

Health maint/preventive medicine

1.4

14.6

11936

116971

H57.1

ICD-10 Finland

Ocular pain

1.5

14.6

405

2672

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

14.5

1684

13898

J01FA06

ATC

roxithromycin; oral

1.2

14.5

4240

38112

R25.1

ICD-10 Finland

Tremor, unspecified

1.6

14.3

294

1807

105

Kela drug reimbursment

Adrenal cortical hypofunction

4.2

14.3

R49.08

ICD-10 Finland

Other specified dysphonia

1.8

14.2

228

1312

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

14.2

2803

24380

TPH07

NOMESCO Finland

Cathetrisation of artery

1.3

14.2

989

7664

R60.0

ICD-10 Finland

Localized oedema

1.3

14.2

1268

10151

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

14.2

1435

11662

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.6

14.2

321

N06AX11

ATC

mirtazapine; oral

1.2

14.1

3726

33206

A12AA06

ATC

calcium lactate gluconate; oral

5.7

14.1

WX002

NOMESCO Finland

Sedation and analgesia

1.2

14.0

1847

15450

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

14.0

1327

10700

107

Kela drug reimbursment

Pernicious anaemia

1.9

14.0

171

905

J01FA09

ATC

clarithromycin; systemic

1.2

14.0

3306

29195

A10BK01

ATC

dapagliflozin; oral

1.4

14.0

666

4871

2AB04, ,

NOMESCO Finland

4.1

13.9

UJF32

NOMESCO Finland

Coloscopy

1.2

13.9

2616

22651

R01AD08

ATC

fluticasone; nasal

1.2

13.8

3022

26506

A60

ICPC

General and Unspecified, Result test/procedure

1.5

13.8

417

2801

M03BX02

ATC

tizanidine; oral

1.2

13.8

7018

65653

R01AD09

ATC

mometasone; nasal

1.2

13.8

5059

46226

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

13.6

2204

18811

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

13.6

2378

20444

177

Kela drug reimbursment

Insulin glargine 300 U / ml

1.9

13.6

162

850

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

13.6

2102

17864

G44.2

ICD-10 Finland

Tension-type headache

1.2

13.5

1489

12215

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

4.8

13.5

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

13.5

1346

10917

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

2.4

13.5

359

E21.0

ICD-10 Finland

Primary hyperparathyroidism

1.8

13.4

201

1134

M25.5

ICD-10 Finland

Pain in joint

1.2

13.3

3663

32716

AS7

Arrhythmia pacemaker insertion VVI (R) S

5.6

13.3

205

Kela drug reimbursment

Chronic hypertension

1.2

13.3

2303

19779

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

13.3

2677

23305

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.4

13.2

750

5642

L04AA06

ATC

mycophenolic acid; systemic

1.9

13.2

170

917

R60.9

ICD-10 Finland

Oedema, unspecified

1.4

13.1

561

4029

R03BA02

ATC

budesonide; inhalant

1.2

12.8

1838

15497

A97

ICPC

No disease

1.2

12.8

2047

17442

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

2.1

12.8

112

526

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

12.8

1153

9240

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.5

12.7

346

2274

D01

ICPC

Abdominal pain/cramps general

1.3

12.7

1299

10561

L17

ICPC

Foot/toe symptom/complaint

1.2

12.7

3308

29398

M54.5

ICD-10 Finland

Low back pain

1.2

12.7

4049

36547

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

12.6

2829

24836

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

12.6

894

6943

E83.50

ICD-10 Finland

Hypercalcemia

1.9

12.6

144

746

R55

ICD-10 Finland

Syncope and collapse

1.3

12.6

993

7822

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

3.7

12.6

106

T90

ICPC

Diabetes non-insulin dependent

1.2

12.6

2198

18881

D11

ICPC

Diarrhoea

1.3

12.5

1240

10046

O992, E050,

ICD-10 Finland

+∞

12.5

L03

ICPC

Low back symptom/complaint

1.2

12.5

3219

28583

C07AB03

ATC

atenolol; systemic

1.4

12.4

466

3270

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

12.4

1922

16328

Z94.1

ICD-10 Finland

Heart transplant status

4.5

12.3

C10AA05

ATC

atorvastatin; oral

1.2

12.3

4072

36832

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

12.2

753

5733

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

1.8

12.2

171

947

2504

FHL

Unilateral resection or enucleation

2.4

12.2

333

WX290

NOMESCO Finland

Other blockage of nerve

1.1

12.1

5043

46343

A12BA01

ATC

potassium chloride; oral

1.5

12.1

350

2331

BAA20

NOMESCO Finland

Unilateral partial excision of thyroid gland

3.2

12.1

148

A08

ICPC

Swelling

1.4

12.1

558

4061

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

12.1

2890

25492

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

12.1

2710

23782

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.7

12.1

246

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.2

12.1

1453

12030

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

12.0

8242

78343

Z3229

NOMESCO Finland

Other healthcare associate professional

1.3

12.0

730

5547

2441A

ICD-9 Finland

Acquired hypothyroidism, Other postablative hypothyroidism

21.3

12.0

C10AX09

ATC

ezetimibe; oral

1.2

12.0

1512

12580

G04BE03

ATC

sildenafil; oral

2.3

12.0

398

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

1.9

11.9

151

810

SPAT1254

SPAT

Administration of medicine

1.2

11.9

1368

11270

F29

ICPC

Eye symptom/complaint other

1.3

11.9

1080

8660

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

2.1

11.8

115

563

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

11.8

2822

24891

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

9.6

11.7

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.5

11.7

305

1989

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.2

11.6

1315

10810

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

11.6

272

1729

SPAT1301

SPAT

No procedures

1.2

11.6

3126

27818

J20

ICD-10 Finland

Acute bronchitis

1.3

11.6

1049

8405

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

11.6

940

7431

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

11.5

1724

14585

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

2.0

11.5

127

651

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

3.2

11.5

143

24599

ICD-8 Finland

Thyroiditis, Unspecified

+∞

11.5

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.3

11.4

873

6848

R05

ICPC

Cough

1.2

11.4

2689

23675

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

4.8

11.4

A09

ICPC

Sweating problem

1.9

11.4

134

702

R03BA05

ATC

fluticasone; inhalant

1.2

11.4

1826

15550

C09AA02

ATC

enalapril; systemic

1.2

11.4

1644

13861

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

2.4

11.4

295

W84

ICPC

Pregnancy high risk

1.6

11.3

288

1867

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

11.3

959

7625

A10BA02

ATC

metformin; oral

1.2

11.3

2558

22450

H02AB04

ATC

methylprednisolone; systemic

1.2

11.3

1422

11826

R06AE07

ATC

cetirizine; oral

1.1

11.2

4954

45637

M79.1

ICD-10 Finland

Myalgia

1.2

11.2

1550

13015

C01DA14

ATC

isosorbide mononitrate; oral

1.2

11.1

1188

9706

CA1BD

NOMESCO Finland

Extensive orbita CT

8.0

11.0

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

11.0

672

5110

N03AX12

ATC

[U] gabapentin; oral

1.2

11.0

1575

13265

OAB50, ,

SPAT

1.3

11.0

721

5541

FM1CD

NOMESCO Finland

Very extensive CT of heart

3.5

11.0

102

C08DA01

ATC

verapamil; systemic

1.5

10.9

365

2506

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.1

10.9

4978

45929

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

2.0

10.9

106

520

S97

ICPC

Chronic ulcer skin

1.4

10.9

523

3834

CE2W4

NOMESCO Finland

Eye movement mapping

4.1

10.8

N03AX16

ATC

[U] pregabalin

1.2

10.8

2315

20212

N07BA03

ATC

varenicline; oral

1.4

10.8

410

2888

I48.3

ICD-10 Finland

Typical atrial flutter

2.2

10.7

404

B01AE07

ATC

dabigatran etexilate; oral

1.5

10.7

298

1971

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.5

10.7

313

2092

7AX01, ,

NOMESCO Finland

17.8

10.7

CKC12

NOMESCO Finland

Photocoagulation of retina

1.5

10.7

345

2354

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

10.7

557

4137

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

10.7

7445

70530

P01AB01

ATC

metronidazole; oral, rectal

1.1

10.6

4463

40930

S18

ICPC

Laceration/cut

1.1

10.6

4909

45301

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.2

10.6

1151

9416

SPAT1255

SPAT

Intravenous administration of medicine

1.4

10.6

571

4262

C03AA03

ATC

hydrochlorothiazide; oral

1.3

10.6

794

6215

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

1.8

10.5

150

837

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.2

10.5

408

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.8

10.5

148

823

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

9.1

10.5

UKC02

NOMESCO Finland

Cystoscopy

1.2

10.5

1210

9971

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

10.4

826

6511

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.5

10.4

328

2229

S06.0

ICD-10 Finland

Concussion

1.3

10.4

1008

8147

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

10.3

932

7465

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

10.3

483

3526

SGA01

NOMESCO Finland

Emergency treatment

1.2

10.3

1547

13084

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

4.2

10.3

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

10.3

3311

29802

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.2

10.3

1248

10332

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

8.8

10.2

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

4.4

10.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

10.2

868

6903

H50.0

ICD-10 Finland

Convergent concomitant strabismus

2.4

10.2

280

A02BA02

ATC

ranitidine; systemic

1.2

10.2

1779

15260

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

10.2

1943

16799

K05

ICPC

Irregular heartbeat other

1.5

10.1

287

1908

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

10.1

921

7390

SPAT1310

SPAT

Counselling related to known health issue

1.2

10.1

3152

28314

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

10.0

2317

20346

R07.3

ICD-10 Finland

Other chest pain

1.3

10.0

983

7953

H3603, E103,

ICD-10 Finland

2.2

10.0

364

M14.5*E03.9

ICD-10 Finland

Arthropathy in hypothyroidism (E00-E03+)

3.4

10.0

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

3.4

10.0

104

A02BC03

ATC

lansoprazole; oral

1.2

10.0

2855

25481

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.2

9.9

1249

10383

L13

ICPC

Hip symptom/complaint

1.2

9.9

2056

17895

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

9.9

1546

13124

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

7.6

9.9

OAB42

NOMESCO Finland

Guidance related to known health problem

3.1

9.9

130

E21.2

ICD-10 Finland

Other hyperparathyroidism

2.8

9.9

173

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

3.1

9.8

125

ZYC01

NOMESCO Finland

Remote contact by phone

1.3

9.8

569

4297

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.2

9.8

1175

9716

J45.1

ICD-10 Finland

Nonallergic asthma

1.3

9.8

654

5040

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.4

9.8

424

3058

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

1.6

9.7

225

1429

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.5

9.7

279

1859

-60

ICPC

Result test/procedure

1.4

9.7

513

3819

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

9.7

694

5399

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.6

9.7

190

1160

3AC01, ,

NOMESCO Finland

2.1

9.6

390

K77

ICPC

Heart failure

1.7

9.6

181

1094

M01AE03

ATC

ketoprofen; systemic, rectal

1.1

9.6

3663

33336

SPAT1312

SPAT

General health counselling

1.1

9.6

3173

28602

G04CA02

ATC

tamsulosin; oral

1.2

9.5

1180

9797

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

9.5

937

7590

BA1MN

NOMESCO Finland

Thyroid gland isotope imaging with calculation

100.1

9.4

2451A

ICD-9 Finland

Thyroiditis, Subacute thyroiditis

+∞

9.4

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.6

9.3

228

1468

J02AC01

ATC

fluconazole; systemic

1.1

9.3

4741

43903

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.4

9.3

399

2872

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.3

9.3

571

4349

C10AA07

ATC

rosuvastatin; oral

1.1

9.3

3355

30407

N17

ICPC

Vertigo/dizziness

1.2

9.3

1287

10804

MAA00

NOMESCO Finland

Amniocentesis

1.6

9.2

183

1121

D06

ICPC

Abdominal pain localized other

1.2

9.2

930

7554

J01MA02

ATC

ciprofloxacin; systemic

1.1

9.1

3817

34914

R01AD12

ATC

fluticasone furoate; nasal

1.1

9.1

3346

30348

WX320

NOMESCO Finland

Spinalanesthesy

1.2

9.1

2440

21658

2440A

ICD-9 Finland

Acquired hypothyroidism, Postsurgical hypothyroidism

8.3

9.0

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

2.2

9.0

354

R07.0

ICD-10 Finland

Pain in throat

1.3

9.0

706

5559

SFA10

NOMESCO Finland

One-surface restoration

1.1

9.0

6003

56452

A01

ICPC

Pain general/multiple sites

1.2

9.0

1018

8371

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

9.0

776

6188

ZXA00

NOMESCO Finland

Right side

1.2

8.9

2472

21983

SFA20

NOMESCO Finland

Two-surface restoration

1.1

8.9

6421

60623

T08

ICPC

Weight loss

1.7

8.9

149

872

N06AX21

ATC

duloxetine; oral

1.2

8.9

1217

10197

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

8.9

448

3312

WF099

NOMESCO Finland

Other radiotherapy

2.4

8.9

230

B01AF03

ATC

edoxaban; oral

1.6

8.9

182

1124

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

8.9

1251

10515

-50

ICPC

Medication/prescr/renewal

1.4

8.9

336

2368

SPAT1260

SPAT

Consultation of another employee

1.2

8.8

1668

14394

TKC20

NOMESCO Finland

Catheterisation of bladder

1.3

8.8

502

3782

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

8.8

1102

9152

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.4

8.8

333

2346

ZXA05

NOMESCO Finland

Left side

1.2

8.8

2289

20262

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.4

8.8

362

2589

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

8.8

2170

19133

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.1

8.8

4074

37481

WX882

NOMESCO Finland

High dependency care

1.6

8.8

201

1276

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

8.6

8.8

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.3

8.7

646

5050

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.3

8.7

548

4190

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

1.9

8.7

110

594

I48.4

ICD-10 Finland

Atypical atrial flutter

2.4

8.6

240

B02AA02

ATC

tranexamic acid; systemic

1.2

8.6

1609

13876

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.2

8.6

909

7420

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.3

8.6

784

6293

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.4

8.6

319

2242

A27

ICPC

Fear of other disease NOS

1.3

8.5

462

3456

K30

ICD-10 Finland

Functional dyspepsia

1.2

8.5

1157

9690

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.4

8.5

356

2554

Z2446

NOMESCO Finland

Social worker

1.3

8.5

525

4004

C01BB02

ATC

mexiletine; systemic

4.0

8.5

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

8.5

776

6227

T72

ICPC

Benign neoplasm thyroid

3.1

8.5

110

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.6

8.5

192

1216

J01MA12

ATC

levofloxacin; systemic

1.2

8.5

1628

14069

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

6.4

8.5

XF640, ,

NOMESCO Finland

1.6

8.4

202

1297

A03

ICPC

Fever

1.2

8.4

1667

14442

R4110, ,

SPAT

1.2

8.4

1362

11597

I49.1

ICD-10 Finland

Atrial premature depolarization

1.4

8.4

335

2384

N05CF02

ATC

zolpidem; oral

1.2

8.4

1748

15208

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

8.4

338

2411

C09CA01

ATC

losartan; oral

1.1

8.3

2434

21717

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

6.7

8.3

3762A

ICD-9 Finland

Disorders of the orbit, Endocrine exophthalmos

+∞

8.3

24509

ICD-8 Finland

Thyroiditis, Unspecified

+∞

8.3

E03.82

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

4.0

8.3

I20.09

ICD-10 Finland

Unstable angina

1.4

8.3

398

2922

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.4

8.3

306

2149

A10BH05

ATC

linagliptin; oral

1.4

8.3

389

2848

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

2.7

8.2

150

EB1VA, ,

NOMESCO Finland

1.2

8.2

1778

15510

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.3

8.2

602

4700

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

2.6

8.2

173

E03.4

ICD-10 Finland

Atrophy of thyroid (acquired)

7.0

8.2

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.5

8.2

258

1755

R5110, ,

SPAT

1.2

8.2

829

6730

XF602

NOMESCO Finland

Bloodpressure monitoring

1.9

8.2

100

533

P06

ICPC

Sleep disturbance

1.2

8.2

1264

10715

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.4

8.2

293

2046

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.2

8.2

1134

9519

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

7.5

8.1

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.0

8.1

113

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

8.1

692

5509

R96

ICPC

Asthma

1.2

8.1

985

8158

6481B

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Thyroid dysfunction[HYPOTHYREOSIS IN GRAVIDITATE]

4.7

8.1

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.3

8.1

466

3520

UJF30

NOMESCO Finland

Ileoscopy through colon

1.2

8.1

981

8124

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.3

8.1

698

5567

N05AN01

ATC

lithium; oral

1.6

8.1

190

1216

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.5

8.0

259

1772

N02AA05

ATC

oxycodone; systemic

1.2

8.0

1642

14263

Z02.7

ICD-10 Finland

Issue of medical certificate

1.3

8.0

667

5296

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.4

8.0

314

2231

5790A

ICD-9 Finland

Intestinal malabsorption, Coeliac disease

3.8

8.0

J37.0

ICD-10 Finland

Chronic laryngitis

1.4

7.9

284

1982

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.3

7.9

559

4344

L14

ICPC

Leg/thigh symptom/complaint

1.3

7.9

769

6219

K07

ICPC

Swollen ankles/oedema

1.4

7.9

421

3145

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.3

7.9

527

4067

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.4

7.9

406

3017

WX740

NOMESCO Finland

Nitrogen oxide therapy

2.7

7.9

154

TK810

NOMESCO Finland

Hemofiltration

2.5

7.9

189

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.6

7.9

159

981

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.2

7.8

1101

9252

M03BC01

ATC

orphenadrine (citrate); systemic

1.1

7.8

2224

19799

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

1.7

7.8

141

845

EBA00

NOMESCO Finland

Extraction of tooth

1.1

7.8

3607

33128

M05BA04

ATC

alendronic acid; oral

1.2

7.8

857

7027

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

2.2

7.7

271

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

1.5

7.7

254

1745

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

2.3

7.7

240

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.4

7.7

321

2304

L15

ICPC

Knee symptom/complaint

1.1

7.7

2651

23908

SPAT1229

SPAT

Assessment of need for aid

1.3

7.6

654

5210

I42

ICD-10 Finland

Cardiomyopathy

4.5

7.6

F01

ICPC

Eye pain

1.4

7.6

273

1907

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.2

7.6

853

7007

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

2.1

7.6

319

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

1.6

7.6

157

975

L95

ICPC

Osteoporosis

1.4

7.6

402

3002

SPAT1283

SPAT

Restricted health certificate

1.2

7.6

1620

14119

R01BA52

ATC

pseudoephedrine, combinations; oral

1.1

7.5

3111

28368

BAA99

NOMESCO Finland

Other operation on thyroid gland

8.8

7.5

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

7.5

374

2766

M54.6

ICD-10 Finland

Pain in thoracic spine

1.3

7.5

714

5761

A28

ICPC

Limited function/disability NOS

1.2

7.5

1612

14059

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.3

7.4

618

4906

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.1

7.4

322

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

7.4

385

2865

E06

ICD-10 Finland

Thyroiditis

4.4

7.4

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

7.4

1760

15460

JN4AD

NOMESCO Finland

Body CT examination

1.2

7.4

961

8013

C08CA13

ATC

lercanidipine; oral

1.2

7.4

1320

11332

M02AA07

ATC

piroxicam; topical

1.1

7.4

3618

33317

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.3

7.4

705

5691

D09

ICPC

Nausea

1.3

7.4

426

3222

C08CA02

ATC

felodipine; oral

1.2

7.4

766

6242

2419X

ICD-9 Finland

Non-toxic nodular goitre, Unspecified non-toxic nodular goitre

2.6

7.4

148

SPAT1216

SPAT

Assessment of functional ability

1.2

7.3

1391

12002

M01AB55

ATC

diclofenac, combinations; oral

1.3

7.3

574

4523

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

2.6

7.3

154

2452A

ICD-9 Finland

Thyroiditis, Chronic lymphocytic thyroiditis

+∞

7.3

I43.8*E05.9

ICD-10 Finland

Thyrotoxic heart disease

+∞

7.3

R03DC03

ATC

montelukast; oral

1.2

7.3

1671

14642

R4130

NOMESCO Finland

Speech therapy

1.5

7.3

201

1335

R52.9

ICD-10 Finland

Pain, unspecified

1.2

7.3

1013

8507

Z01.2

ICD-10 Finland

Dental examination

1.1

7.2

5101

47898

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.4

7.2

363

2687

GD1AD

NOMESCO Finland

Thorax CT examination

1.3

7.2

506

3931

E66.9

ICD-10 Finland

Obesity, unspecified

1.4

7.2

322

2339

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.5

7.2

230

1572

E07

ICD-10 Finland

Other disorders of thyroid

6.2

7.2

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.3

7.2

459

3520

E66.8

ICD-10 Finland

Other obesity

1.3

7.2

522

4074

SPAT1104

SPAT

Monitoring of emergency patient

1.3

7.2

532

4163

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

1.3

7.2

671

5402

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.2

7.2

830

6842

SPAT1153

SPAT

Removal of sutures

1.1

7.2

2974

27118

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.3

7.1

462

3551

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

2.2

7.1

274

SFA30

NOMESCO Finland

Three-surface restoration

1.1

7.1

4375

40774

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.3

7.1

479

3701

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.4

7.1

356

2636

PD5AD

NOMESCO Finland

CT of aorta

1.6

7.1

169

1086

R74

ICPC

Upper respiratory infection acute

1.1

7.1

3535

32572

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.3

7.1

557

4393

T99

ICPC

Endocr/metab/nutrit disease other

1.6

7.1

137

838

A01AB09

ATC

miconazole; local oral

1.2

7.1

793

6517

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

2.5

7.1

175

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.3

7.0

371

2770

WX872

NOMESCO Finland

Intensive care

1.4

7.0

344

2540

M54

ICD-10 Finland

Dorsalgia

1.2

7.0

1209

10352

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

7.0

1438

12491

WX722

NOMESCO Finland

PEEP

1.4

7.0

320

2336

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.3

7.0

422

3214

K29

ICPC

Cardiovascular sympt/complt other

1.4

7.0

352

2610

J45

ICD-10 Finland

Asthma

1.2

7.0

1020

8605

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.3

7.0

448

3442

E27.2

ICD-10 Finland

Addisonian crisis

4.4

6.9

K84

ICPC

Heart disease other

1.5

6.9

206

1389

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.2

6.9

1110

9444

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.3

6.9

385

2899

SPAT1211

SPAT

Application of soft bandage

1.2

6.9

745

6100

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

1.8

6.8

530

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

3.3

6.8

R20.2

ICD-10 Finland

Paraesthesia of skin

1.2

6.8

672

5446

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.1

6.8

2957

27026

CBK99

NOMESCO Finland

Other operation for retraction of eyelid

9.3

6.8

R33

ICD-10 Finland

Retention of urine

1.3

6.8

479

3729

Z00.0

ICD-10 Finland

General medical examination

1.2

6.8

1803

15968

A13

ICPC

Concern/fear medical treatment

1.5

6.8

180

1187

H26.4

ICD-10 Finland

After-cataract

1.2

6.7

921

7720

H50.52

ICD-10 Finland

Exophoria

1.8

6.7

547

LCA06

NOMESCO Finland

Biopsy of endometrium

1.2

6.7

1311

11338

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

2.9

6.7

104

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.2

6.7

752

6182

H36.01

ICD-10 Finland

Diabetic maculopathy

1.8

6.7

512

M01AH02

ATC

rofecoxib; oral

1.2

6.7

1137

9723

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.5

6.7

222

1532

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

6.7

636

5135

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.3

6.7

376

2836

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.3

6.6

381

2881

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

3.7

6.6

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

6.4

6.6

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.3

6.6

420

3222

I34.1

ICD-10 Finland

Mitral (valve) prolapse

1.5

6.6

190

1274

D07AD01

ATC

clobetasol; topical

1.2

6.6

1661

14654

S16

ICPC

Bruise/contusion

1.4

6.6

256

1820

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

1.7

6.5

121

732

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.3

6.5

473

3694

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.3

6.5

443

3430

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.2

6.5

848

7074

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.2

6.5

1080

9213

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

2.6

6.5

140

N19

ICD-10 Finland

Unspecified kidney failure

1.4

6.5

257

1831

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

6.8

6.5

B82

ICPC

Anaemia other/unspecified

1.4

6.5

229

1598

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.3

6.5

366

2762

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

1.8

6.5

532

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

1.7

6.5

108

636

TBA20

NOMESCO Finland

Aspiration cytology of thyroid gland

5.3

6.4

K59.1

ICD-10 Finland

Functional diarrhoea

1.3

6.4

515

4073

J01DA09

ATC

[U] cefadroxil

1.1

6.4

2577

23429

H05.0

ICD-10 Finland

Acute inflammation of orbit

3.9

6.4

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

2.6

6.4

141

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

1.6

6.4

145

922

K08.3

ICD-10 Finland

Retained dental root

1.2

6.4

633

5131

WZC00, ,

SPAT

1.2

6.4

1444

12629

Z00.8

ICD-10 Finland

Other general examinations

1.2

6.4

710

5828

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.2

6.4

995

8441

E50.9

ICD-10 Finland

Vitamin A deficiency, unspecified

7.4

6.4

H05.1

ICD-10 Finland

Chronic inflammatory disorders of orbit

7.4

6.4

3025

Kela drug reimbursment

Calcium carbonate

2.3

6.4

196

TK800

NOMESCO Finland

Hemodialysis

1.6

6.4

139

876

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

6.4

4082

38074

ZX108

NOMESCO Finland

Inhalation

2.1

6.4

274

M01AE02

ATC

naproxen; oral, rectal

1.1

6.4

6135

58377

TFP45

NOMESCO Finland

Ablation treatment of non-typical atrial flutter

3.7

6.3

N05BA01

ATC

diazepam; systemic, rectal

1.2

6.3

1148

9868

E87.5

ICD-10 Finland

Hyperkalaemia

1.6

6.3

133

831

J01DA06

ATC

[U] cefuroxime

1.2

6.3

1320

11477

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

2.0

6.3

322

L08

ICPC

Shoulder symptom/complaint

1.1

6.3

2303

20814

BEF00, ,

SPAT

1.9

6.3

350

PH3AC

NOMESCO Finland

Flebography of internal organs with X-ray

3.6

6.3

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

2.8

6.3

108

E66.00

ICD-10 Finland

Metabolic syndrome

1.3

6.3

443

3449

R4120

NOMESCO Finland

Occupational therapy

1.3

6.3

557

4462

E8901, E050,

ICD-10 Finland

+∞

6.2

H060, E050,

ICD-10 Finland

+∞

6.2

C08CA05

ATC

nifedipine; systemic

1.3

6.2

467

3663

R31

ICD-10 Finland

Unspecified haematuria

1.2

6.2

682

5591

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

2.2

6.2

211

WVA20

NOMESCO Finland

Medicine administration

1.4

6.2

221

1545

2428X

ICD-9 Finland

Thyrotoxicosis with or without goitre, Thyrotoxicosis of other specified origin

26.7

6.2

R4190

NOMESCO Finland

Nutritional therapy

1.4

6.2

322

2400

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1.5

6.2

201

1382

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.5

6.2

198

1358

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.2

6.2

1291

11228

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

2.3

6.2

193

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.7

6.2

113

683

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.1

6.2

3134

28873

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

3.5

6.1

N01

ICPC

Headache

1.2

6.1

1075

9215

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.2

6.1

952

8075

H02AA02

ATC

fludrocortisone; oral

2.0

6.1

326

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.5

6.1

181

1222

M48.0

ICD-10 Finland

Spinal stenosis

1.2

6.1

1064

9117

KH1AD

NOMESCO Finland

CT of urinary organs

1.4

6.1

256

1844

E87.6

ICD-10 Finland

Hypokalaemia

1.4

6.1

295

2175

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.3

6.1

378

2892

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

3.8

6.1

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.3

6.1

436

3404

CS494

NOMESCO Finland

Other visual field testing

1.4

6.1

205

1421

BA1AQ

NOMESCO Finland

Thyroid SPECT with low dose CT

8.6

6.0

A10BH01

ATC

sitagliptin; oral

1.2

6.0

731

6057

B01AB04

ATC

dalteparin; parenteral

1.3

6.0

436

3406

TQW11

NOMESCO Finland

Vacuum treatment of wound

1.5

6.0

156

1024

M54.4

ICD-10 Finland

Lumbago with sciatica

1.1

6.0

1826

16309

C02AC05

ATC

moxonidine; oral

1.3

6.0

340

2568

D07AC01

ATC

betamethasone; topical

1.1

6.0

3689

34314

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

7139

6591

23.67

307.65

6.8

2.5

4.81

4.37

pmol/l

104.35

6735

5831

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

6245

1944

62.68

307.65

2.7

1.4

18.34

10.73

iu/l

0.38

3193

644

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11891

90512

6.53

307.65

14.5

4.4

15.70

14.68

pmol/l

321.33

11537

83669

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3831

8404

6.11

307.65

1.4

1.2

190.82

135.70

u/ml

8.96

1731

3141

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8130

57541

2.16

307.65

8.5

6.9

1.22

mmol/l

1.09

7069

49644

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7295

51305

2.00

302.19

7.6

6.2

1.22

mmol/l

0.23

6856

47423

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12033

104228

4.40

301.18

16.1

5.4

1.66

1.89

mu/l

37.34

11652

97208

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2066

9047

2.54

287.86

3.5

3.6

69.00

86.02

ng/l

15.07

1817

7747

(3013650) Neutrophils [#/volume] in Blood by Automated count

8673

65505

2.04

285.08

10.1

9.7

3.93

4.06

e9/l

5.80

7492

56812

(3018418) pH of Serum or Plasma

5409

34944

1.96

279.72

5.0

4.1

7.40

2.69

4025

24785

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

306

357

8.76

241.09

1.7

1.4

17.23

14.41

pmol/l

3.85

273

291

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10247

86328

2.00

194.45

9.8

8.2

79.28

78.37

u/l

1.33

9873

81963

(3015377) Calcium [Moles/volume] in Serum or Plasma

5674

40908

1.70

177.38

3.3

3.5

2.35

2.36

mmol/l

12.72

5199

37205

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

9902

84542

1.80

152.53

4.9

4.5

12.00

12.21

mm/h

0.82

9388

79351

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

427

1099

3.99

145.68

4.1

5.5

150.83

102.90

u/ml

0.62

153

362

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7023

55181

1.62

144.78

2.8

2.5

76.78

1706.36

nmol/l

0.50

6442

50361

(3013115) Eosinophils [#/volume] in Blood

7523

60488

1.60

137.58

6.6

6.5

0.19

e9/l

0.09

6595

52909

(3006315) Basophils [#/volume] in Blood

7306

58719

1.58

130.51

6.4

6.3

0.04

e9/l

5.97

6289

50471

(3022096) Basophils/Leukocytes in Blood

6787

53702

1.57

129.20

6.6

0.67

0.69

3.61

6348

50299

(3019069) Monocytes/Leukocytes in Blood

6799

53850

1.57

128.62

6.6

8.75

8.67

1.33

6357

50542

(3019198) Lymphocytes [#/volume] in Blood

7412

59883

1.58

128.46

6.4

1.86

1.92

e9/l

2.39

6542

52748

(3006504) Eosinophils/Leukocytes in Blood

6785

53731

1.57

128.30

6.6

6.5

2.82

0.05

6351

50379

(3002030) Lymphocytes/Leukocytes in Blood

6928

55155

1.57

127.74

6.5

27.78

28.24

3.05

6544

52287

(3001604) Monocytes [#/volume] in Blood

7276

58576

1.57

127.72

6.4

6.3

0.57

e9/l

0.00

6269

50377

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

753

2962

2.64

126.50

1.2

1.3

—

(3018010) Neutrophils/Leukocytes in Blood

6777

54173

1.54

118.89

6.4

57.28

57.12

0.54

6467

51770

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1925

11372

1.82

113.40

2.4

2.2

375.98

380.65

nmol/l

0.47

1781

10507

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4354

32157

1.54

105.94

4.3

3.0

1347.68

1266.78

ng/l

0.73

3784

27588

(3013826) Glucose [Moles/volume] in Serum or Plasma

7828

65516

1.51

103.74

5.8

4.8

6.67

6.60

mmol/l

1.77

7455

61771

(3021589) Normoblasts [#/volume] in Blood

6302

50546

1.49

102.08

13.1

11.3

0.00

e9/l

0.23

5162

41060

(3001019) Free T4 and TSH panel - Serum or Plasma

1189

6199

2.01

101.79

2.3

1.7

—

(40758558) Short blood count panel - Blood

4600

34818

1.51

97.57

7.2

6.3

—

(3044889) 12 lead EKG panel

8858

76571

1.53

96.81

4.9

3.9

0.46

2902.04

0.68

142

(3019550) Sodium [Moles/volume] in Serum or Plasma

11835

110632

2.14

91.69

23.4

17.8

139.70

139.67

mmol/l

0.71

11688

108467

(3023103) Potassium [Moles/volume] in Serum or Plasma

11849

110824

2.15

91.47

23.7

18.0

3.95

mmol/l

0.19

11681

108469

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3883

28669

1.51

91.31

1.4

1.3

1.72

1.64

u/ml

0.16

1058

7928

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

271

711

3.87

89.91

5.3

7.3

53.51

69.78

ug/l

0.20

182

461

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2748

18919

1.58

88.34

3.8

3.3

0.81

0.82

mmol/l

1.50

2585

17760

(3032080) INR in Blood by Coagulation assay

6138

50032

1.44

84.99

19.6

13.5

1.29

1.22

inr

19.83

5227

41449

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2196

14496

1.62

83.66

5.7

5.5

1.05

1.04

mmol/l

0.74

2033

13436

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7130

60051

1.43

80.64

6.7

6.4

10.98

10.88

umol/l

0.32

6790

57111

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

11301

104746

1.76

79.62

19.3

15.0

81.78

81.72

ml/min/173m2

0.10

10645

96695

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6871

57723

1.42

77.26

3.7

3.2

103.71

106.78

ug/l

0.69

6430

54080

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11667

109383

1.89

76.24

19.4

15.6

21.30

22.78

mg/l

5.76

9970

89937

(3007164) IgA [Mass/volume] in Serum or Plasma

3317

24441

1.48

75.80

1.5

2.25

2.33

g/l

1.92

1986

14999

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2597

18189

1.54

75.66

2.8

2.5

2.37

2.36

g/l

0.57

2387

16765

(3024561) Albumin [Mass/volume] in Serum or Plasma

6213

51559

1.40

73.28

5.0

4.8

35.67

35.85

g/l

1.90

5838

48292

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3986

30636

1.44

72.39

2.6

2.4

2.82

2.79

mg/l

0.21

3477

26583

(3022948) Iron [Moles/volume] in Serum or Plasma

2749

19664

1.51

72.03

2.8

2.5

13.15

13.02

umol/l

0.39

2557

18282

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5156

41539

1.41

71.69

4.4

3.6

57.93

64.67

ng/l

0.14

3453

27398

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2379

16712

1.52

67.32

2.9

2.6

21.96

22.15

0.29

2202

15495

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12023

114639

2.05

63.11

15.6

12.1

24.27

24.94

u/l

4.08

11832

111406

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10993

102245

1.59

63.00

7.1

6.1

39.58

38.79

mmol/mol

15.81

10330

95874

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6006

50710

1.35

57.88

2.3

2.1

96.81

98.00

pmol/l

1.07

3254

26064

(3027456) Digoxin [Moles/volume] in Serum or Plasma

463

2081

2.27

57.56

3.6

3.3

0.83

0.82

nmol/l

0.23

380

1668

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12046

115392

1.99

55.23

25.6

19.9

74.29

73.20

umol/l

3.55

11952

114061

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11176

104922

1.57

54.95

5.6

5.0

5.94

5.85

mmol/l

10.00

10338

96902

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1398

9123

1.60

53.86

4.0

3.8

1.23

mmol/l

3.34

1228

7834

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2809

21303

1.41

51.42

4.8

3.8

390.44

377.77

ng/l

0.02

2164

15852

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3353

26207

1.38

51.27

2.5

1.7

1.08

1.17

mg/l

1.30

2575

20328

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4232

34603

1.34

47.45

2.3

2.2

181.70

189.04

u/l

0.14

4020

32662

(3013512) EKG study

4571

37906

1.32

46.08

4.2

3.5

0.82

0.76

0.19

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1540

10629

1.51

45.68

4.1

3.7

5.88

5.82

kpa

1.53

1495

10354

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4429

36698

1.32

44.45

2.8

2.6

64.17

62.38

u/l

0.12

4090

33948

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2422

18337

1.40

43.74

2.0

1.9

—

(3002032) Base excess in Venous blood by calculation

1495

10346

1.50

43.65

4.2

3.7

1.89

1.87

mmol/l

0.06

1328

9104

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3003

23571

1.36

43.34

2.9

2.45

mmol/l

2.45

2643

21179

(3012544) pH of Venous blood

1538

10752

1.49

42.67

4.2

3.7

7.38

0.90

849

6077

(3033658) Prothrombin time (PT) actual/Normal

3576

28916

1.33

42.06

4.6

4.0

89.22

92.43

11.20

3499

28221

(3026782) Osmolality of Urine

2747

21380

1.36

41.57

3.1

2.9

505.40

515.02

mosm/kgh2o

1.56

2403

18675

(3010838) Calcium [Moles/time] in 24 hour Urine

450

2271

2.02

41.48

2.0

1.9

4.77

5.06

mmol/24h

1.14

398

2034

(3037467) Urinalysis macro (dipstick) panel - Urine

8622

78503

1.31

41.11

5.3

4.8

2.51

2.33

—

115

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3517

28561

1.32

39.63

2.4

2.3

—

(3000991) Gas panel - Venous blood

1342

9284

1.50

38.98

10.5

8.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6200

54298

1.28

38.94

2.9

2.7

—

estimate

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

9883

91972

1.35

38.93

26.2

19.0

13.64

13.60

2.62

9787

90780

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8327

75727

1.29

38.49

3.5

3.2

43.96

44.30

u/l

0.14

7895

71252

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

959

6205

1.59

37.72

4.2

3.9

24.46

24.32

mmol/l

0.71

949

6128

(3035637) Corticotropin [Mass/volume] in Plasma

323

1491

2.20

37.66

1.7

1.6

42.33

26.96

ng/l

1.68

323

1485

(3023368) Bacteria identified in Blood by Culture

3621

29697

1.31

37.54

4.6

4.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4545

38455

1.28

36.97

3.3

30.13

33.54

u/l

2.54

4314

36286

(3002582) Erythrocytes [#/volume] in Urine

4347

36659

1.28

36.03

3.8

3.3

89.14

73.50

e6/l

0.26

3323

27602

(3030467) Casts [#/volume] in Urine by Automated count

3818

31734

1.29

35.27

3.7

3.2

0.40

0.41

e6/l

0.09

2799

22962

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1205

8330

1.49

34.94

3.9

2.9

255.53

180.43

ng/l

3.16

1103

7613

(3037522) Nuclear Ab [Titer] in Serum

2253

17435

1.36

34.49

1.4

526.52

532.93

titre

0.06

515

3898

(3019225) pH of Specimen

1502

10882

1.43

34.07

4.9

4.1

7.37

7.36

2.56

1168

7661

(3020779) Urea [Moles/volume] in Serum or Plasma

1312

9272

1.46

33.99

9.7

7.0

9.85

9.45

mmol/l

1.19

1247

8866

(3031040) Bacteria [#/volume] in Urine by Automated count

8335

76297

1.27

33.89

5.6

4.9

2478.47

2497.41

e6/l

0.01

122

965

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11393

109053

1.46

33.75

6.2

5.7

2.71

2.76

mmol/l

10.24

10657

101876

(40760892) CBC W Ordered Manual Differential panel - Blood

3221

26312

1.30

33.63

4.4

4.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1353

9672

1.45

32.94

9.3

7.3

1.27

1.30

mmol/l

0.61

1326

9484

(3020630) Protein [Mass/volume] in Serum or Plasma

1298

9208

1.46

32.91

2.3

2.6

65.56

66.42

g/l

3.97

1196

8400

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11258

107598

1.43

32.85

5.5

5.0

4.63

4.74

mmol/l

24.16

10577

100882

(3027945) Reticulocytes/Erythrocytes in Blood

1667

12379

1.40

32.78

2.5

1.77

1.81

0.70

1504

11018

(3018095) Leukocytes [#/volume] in Urine

4954

42790

1.26

32.73

4.6

3.9

81.43

103.78

e6/l

2.13

3505

29292

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1673

12476

1.39

32.03

5.2

4.3

234.23

242.97

u/l

1.93

1585

11811

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1782

13453

1.38

31.63

2.6

7.47

7.92

umol/l

0.47

1529

11600

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1786

13492

1.38

31.57

1.9

1.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11190

106970

1.41

31.31

5.4

4.9

1.49

1.52

mmol/l

16.31

10449

99770

(3014576) Chloride [Moles/volume] in Serum or Plasma

1931

14788

1.36

31.30

8.5

7.0

104.17

104.25

mmol/l

0.31

1931

14781

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10726

101835

1.36

31.27

4.5

4.2

1.26

mmol/l

0.17

9915

94064

(36660697) Celiac disease serology panel - Serum

1391

10090

1.43

31.18

1.2

—

(36304419) Bacteria [Presence] in Urine

3627

30314

1.28

31.17

3.6

3.1

0.00

140.45

estimate

—

127

(3024354) Oxygen [Partial pressure] in Venous blood

1249

8899

1.45

30.85

3.6

3.2

4.53

4.50

kpa

0.16

1206

8656

(3009508) Creatinine [Moles/volume] in Urine

4393

37645

1.26

30.40

3.7

3.4

7.04

7.07

mmol/l

0.15

3674

31906

(3007461) Platelets [#/volume] in Blood

12161

118410

1.77

30.24

32.8

23.8

258.61

258.14

e9/l

0.36

12028

116126

(3020682) Albumin/Creatinine [Ratio] in Urine

4159

35432

1.26

30.22

4.5

4.1

8.22

8.64

mg/mmol

0.22

2516

21022

(3035941) MCH [Entitic mass]

12162

118433

1.76

30.08

32.6

23.7

30.11

30.24

14.77

12096

117273

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

12162

118444

1.76

29.92

33.5

24.2

40.20

40.36

0.58

12090

117234

(3026361) Erythrocytes [#/volume] in Blood

12162

118445

1.76

29.90

32.8

23.8

4.48

4.44

e12/l

21.63

11977

115809

(3024731) MCV [Entitic mean volume] in Red Blood Cells

12161

118435

1.76

29.86

32.7

23.7

90.80

91.06

8.20

12096

117273

(3000963) Hemoglobin [Mass/volume] in Blood

12163

118463

1.76

29.82

33.0

23.9

133.89

133.30

g/l

5.46

12097

117330

(3021960) Folate [Moles/volume] in Serum or Plasma

3888

32917

1.26

29.67

1.8

1.7

20.05

20.69

nmol/l

1.95

3346

27937

(3010813) Leukocytes [#/volume] in Blood

12162

118464

1.76

29.62

32.8

23.8

6.65

6.68

e9/l

0.78

11982

115812

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1674

12678

1.37

28.93

1.9

1.8

—

(3012516) Albumin [Mass/volume] in Urine

4077

34861

1.25

28.17

3.8

3.4

50.68

44.36

mg/l

0.44

2594

21046

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

924

6344

1.49

27.49

11.4

9.2

24.59

24.33

mmol/l

1.75

908

6223

(3000850) Epithelial cells [#/volume] in Urine

3029

25178

1.27

26.33

3.0

2.7

6.63

6.73

e6/l

0.12

2756

22837

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2254

18055

1.30

26.27

3.5

3.0

3.86

3.54

e6/l

0.52

1116

8492

(40768804) Tissue Pathology biopsy report

5407

47955

1.22

25.82

2.2

2.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

952

6693

1.46

25.05

1.8

1.7

—

(3024928) Oxygen saturation in Venous blood

449

2657

1.72

25.01

3.3

3.0

61.39

60.63

0.30

431

2570

(40768797) Stomach Pathology biopsy report

2059

16453

1.30

24.22

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2324

18972

1.28

22.99

1.8

1.7

1100.90

1179.59

nmol/l

4.34

1816

14372

(3027801) Oxygen [Partial pressure] in Arterial blood

1595

12387

1.33

22.96

8.7

7.4

12.22

12.62

kpa

2.41

1539

11913

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2831

23665

1.25

22.91

1.4

1.3

28.24

32.69

iu/ml

1.04

849

7330

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1595

12391

1.33

22.91

8.7

7.4

5.13

5.10

kpa

0.60

1541

11925

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1435

10989

1.35

22.72

3.5

3.4

—

(3019977) pH of Arterial blood

1593

12409

1.32

22.42

8.8

7.4

7.42

0.06

817

6728

(3021601) Nitrite [Presence] in Urine by Test strip

6747

61653

1.20

22.26

4.4

4.0

0.00

estimate

0.51

1515

12798

(3004119) Hemoglobin [Mass/volume] in Venous blood

916

6539

1.43

22.15

3.6

3.2

131.36

128.13

g/l

4.59

886

6356

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

337

2.95

22.04

1.4

1.7

0.44

0.39

ug/l

0.44

244

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

515

3264

1.60

21.98

4.3

3.2

0.37

0.35

iu/ml

0.35

292

1796

(3003396) Base excess in Arterial blood by calculation

1577

12309

1.32

21.84

8.7

7.3

1.06

0.97

mmol/l

0.37

1303

10185

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2035

16520

1.28

20.84

2.9

2.1

30.05

29.40

4.68

1983

16054

(3035350) Ketones [Presence] in Urine by Test strip

6797

62378

1.19

20.63

4.4

4.0

4.49

4.07

estimate

0.07

1557

13154

(3017732) Neutrophils [#/volume] in Blood

1862

14968

1.29

20.61

3.0

3.1

4.34

4.44

e9/l

0.20

1604

12988

(3016502) Oxygen saturation in Arterial blood

1409

10914

1.33

20.52

9.3

7.7

95.14

95.74

2.36

1363

10536

(3052851) Hemolysis interference index of Serum or Plasma

489

3113

1.59

20.50

3.3

3.1

2.37

1.86

index

0.39

246

1571

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2618

21927

1.24

20.47

1.4

1.3

7.68

11.41

u/ml

2.68

977

8751

(3026493) Urate [Moles/volume] in Serum or Plasma

3368

28997

1.22

20.22

2.7

2.5

331.79

327.07

umol/l

1.77

2915

25557

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

865

6219

1.42

20.08

1.2

1.1

1.49

1.82

u/ml

0.19

(3023520) Reticulocytes [#/volume] in Blood

1244

9507

1.34

19.84

2.4

2.6

72.41

70.09

e9/l

1.20

885

6915

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1439

11235

1.32

19.78

2.6

2.5

100.85

41.94

u/l

0.49

1211

9467

(3009261) Glucose [Presence] in Urine by Test strip

6830

62845

1.19

19.67

4.4

4.1

0.04

0.36

estimate

1.27

1469

12578

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2392

19924

1.25

19.53

3.4

2.9

1.07

1.37

e6/l

1.05

1258

10389

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

578

3869

1.52

19.38

2.0

2.4

0.37

0.84

g/l

4.57

501

3314

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

710

4962

1.46

19.22

1.8

1.7

1.52

1.54

g/l

0.19

615

4262

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

501

3259

1.56

19.15

1.9

2.3

0.01

0.03

g/l

1.58

458

2925

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

711

4986

1.45

18.90

2.3

2.0

39.08

39.73

u/l

0.36

632

4473

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

458

2928

1.59

18.88

1.9

2.3

0.00

g/l

-0.00

434

2734

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

620

4236

1.49

18.83

1.9

2.3

2.97

2.89

g/l

1.22

563

3834

(3010421) pH of Blood

523

3449

1.54

18.80

3.1

3.5

7.41

0.11

518

3409

(3020961) Endomysium IgA Ab [Titer] in Serum

818

5892

1.42

18.78

1.2

1.1

115.35

196.17

titre

1.20

145

(3025159) Blasts/Leukocytes in Blood

1292

10006

1.32

18.76

4.2

4.7

0.04

0.31

3.31

300

2446

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

484

3142

1.56

18.67

1.9

2.3

0.00

g/l

0.47

434

2740

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

305

1771

1.74

18.27

1.3

0.62

2.50

nmol/l

0.92

294

1708

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

646

4479

1.47

18.22

1.9

2.3

4.22

4.26

g/l

0.54

591

4077

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

784

5639

1.42

18.14

3.4

2.9

1.16

1.23

1.58

778

5610

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

311

1821

1.73

18.09

1.2

1.3

0.25

0.24

nmol/l

0.06

115

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

646

4486

1.46

18.08

1.9

2.3

7.48

7.43

g/l

0.26

589

4082

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

588

4008

1.49

18.07

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

644

4477

1.46

17.92

1.9

2.3

3.64

3.66

g/l

0.08

587

4075

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2796

23908

1.22

17.53

1.8

1.7

36687083.10

31659768.15

pmol/l

0.18

2336

19972

(3048689) Calprotectin [Mass/mass] in Stool

1975

16279

1.25

17.50

2.1

2.3

125.82

125.71

ug/g

0.00

1536

12831

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

158

750

2.12

17.41

2.1

1.7

98.58

99.76

ng/l

0.03

158

750

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

921

6861

1.37

17.28

3.7

3.5

5.19

5.16

kpa

0.54

873

6547

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1116

8563

1.33

17.24

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5238

47446

1.18

17.19

2.1

1.9

1.32

1.34

mmol/l

1.62

4333

40028

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

271

1559

1.75

16.81

1.2

1.3

0.19

nmol/l

0.18

201

1184

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

236

1310

1.82

16.53

1.2

72.22

60.30

u/l

1.59

206

1146

(3015736) pH of Urine

5460

49743

1.17

16.41

3.7

3.6

6.23

6.24

0.49

3028

27583

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

560

3855

1.47

16.40

2.0

2.3

9.82

10.13

g/l

1.07

501

3407

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1302

10278

1.30

16.35

9.9

8.1

121.14

119.93

g/l

1.33

1276

10040

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

469

3116

1.52

16.33

1.4

1.5

15.57

15.20

iu/ml

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1377

10984

1.28

15.93

2.2

0.21

g/l

0.21

1286

10257

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

159

784

2.04

15.88

1.4

1.5

12.65

11.96

umol/l

0.53

153

736

(3009343) pH of Capillary blood

887

6657

1.36

15.86

3.7

3.5

7.42

0.22

728

5499

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

466

3117

1.51

15.73

2.5

2.1

11.83

11.43

mg/l

0.54

440

2907

(3009445) Proteinase 3 Ab [Units/volume] in Serum

662

4747

1.42

15.59

1.4

1.6

14.50

14.86

iu/ml

—

126

(3017181) Myelocytes/Leukocytes in Blood

1300

10330

1.29

15.49

4.1

4.4

0.95

0.01

349

3005

(40761536) Microorganisms panel - Urine sediment

1183

9290

1.30

15.42

4.3

4.1

—

(3014051) Protein [Presence] in Urine by Test strip

3817

33913

1.18

15.31

3.3

3.0

0.08

0.06

0.19

793

(3042936) Bacteria identified in Isolate by Culture

1898

15788

1.24

15.30

2.2

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

812

6049

1.37

15.22

11.7

9.4

16.01

15.87

0.70

788

5830

(3021440) Promyelocytes/Leukocytes in Blood

1251

9917

1.29

15.17

4.2

4.5

0.07

0.12

2.11

304

2598

(3022145) Colonoscopy Study observation

1625

13311

1.25

15.03

1.3

1.4

—

(3003694) ABO and Rh group [Type] in Blood

3712

32965

1.18

14.87

1.6

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

536

3735

1.45

14.76

1.8

0.23

g/l

0.32

506

3548

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

548

3838

1.45

14.70

1.8

1.19

g/l

0.10

516

3661

(3002179) Metamyelocytes/Leukocytes in Blood

1235

9820

1.29

14.61

3.9

4.3

0.74

0.72

0.07

340

2821

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

774

5766

1.36

14.50

3.5

3.4

2.04

1.89

mmol/l

0.47

572

4300

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

563

3983

1.43

14.31

1.2

1.3

57.92

40.53

u/ml

0.52

228

(3041096) Erythrocytes [Presence] in Urine by Automated

3746

33390

1.17

14.19

3.9

3.4

0.53

0.30

estimate

0.34

1234

10308

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

140

688

2.05

14.17

1.0

1.1

7.07

7.94

nmol/l

0.07

132

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

233

1352

1.74

14.10

1.3

1.2

38.29

33.86

nmol/l

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

163

851

1.93

13.90

2.3

2.1

17.82

18.26

nmol/l

0.26

150

802

(3005719) IgG [Mass/volume] in Serum or Plasma

1137

9016

1.29

13.72

2.5

2.9

10.24

10.46

g/l

1.04

1040

8342

(3011985) Renin [Units/volume] in Plasma

281

1728

1.64

13.70

2.1

1.5

61.05

59.27

mu/l

0.07

246

1550

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

138

684

2.03

13.66

1.2

1.1

15.91

23.12

u/l

2.06

126

609

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1077

8486

1.29

13.65

2.5

2.3

9.00

6.72

ug/l

1.58

921

7348

(3028026) IgM [Mass/volume] in Serum or Plasma

915

7054

1.32

13.62

1.8

1.9

1.18

1.35

g/l

2.67

855

6491

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

516

3646

1.43

13.22

2.7

3.4

55.02

42.15

mg/l

0.25

444

3084

(3009214) Lutropin [Units/volume] in Serum or Plasma

447

3083

1.47

13.02

1.4

1.3

13.60

12.16

u/l

1.09

356

2493

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

137

690

2.00

12.99

1.1

71.78

81.90

u/l

1.25

126

612

(3034860) Kappa light chains.free [Mass/volume] in Serum

515

3650

1.43

12.98

2.7

3.4

42.91

64.96

mg/l

0.83

444

3086

(3023199) Leukocytes [#/volume] in Pleural fluid

203

1163

1.76

12.89

1.5

1648.99

3660.33

e6/l

1.31

137

808

(3003434) Protein [Mass/volume] in Pleural fluid

224

1321

1.71

12.84

1.5

30.70

33.08

g/l

2.01

198

1207

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

464

3236

1.45

12.77

2.6

3.2

1.44

4.19

ratio

3.03

268

1868

(3021387) Prolactin [Units/volume] in Serum or Plasma

593

4323

1.39

12.72

1.7

291.75

304.40

mu/l

0.50

531

3893

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

531

3817

1.41

12.37

2.9

2.1

335.86

575.02

ug/l

2.18

496

3584

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

586

4302

1.38

12.06

2.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

215

1279

1.69

11.97

2.8

3.5

3.72

9.55

nmol/l

0.74

205

1235

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

895

7002

1.30

11.96

12.1

9.2

1.31

0.10

890

6961

(3023323) Follitropin [Units/volume] in Serum or Plasma

939

7404

1.29

11.82

1.4

29.76

28.85

iu/l

0.36

802

6391

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

511

3705

1.40

11.35

1.3

19.60

6.88

u/ml

1.15

560

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

323

2147

1.52

11.34

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

323

2147

1.52

11.34

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

387

2672

1.46

11.27

2.0

2.2

129.88

127.73

g/l

0.92

272

2055

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

332

2228

1.50

11.14

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

496

3600

1.39

10.96

3.9

3.7

24.99

24.95

mmol/l

0.11

454

3299

(3023420) DNA double strand Ab [Units/volume] in Serum

693

5304

1.32

10.88

1.9

8.63

7.00

iu/ml

0.55

135

1277

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2218

19297

1.18

10.83

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

535

3952

1.37

10.63

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

1014

8178

1.26

10.62

1.4

1.3

168.06

217.63

u/ml

1.43

953

7583

(3022493) Free Hemoglobin [Mass/volume] in Plasma

419

2.16

10.61

19.1

3.0

73.46

546.40

mg/l

0.48

301

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

299

2.38

10.61

1.1

1.2

7.83

10.80

pmol/l

0.66

100

(3015235) Bicarbonate [Moles/volume] in Capillary blood

497

3630

1.38

10.59

2.9

2.8

25.24

24.91

mmol/l

1.00

486

3575

(3036489) Thrombin time

574

4291

1.35

10.57

3.1

2.0

21.51

20.82

0.75

514

3753

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

423

3007

1.42

10.55

1.2

1.3

42.09

48.11

u/ml

0.28

314

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

506

3715

1.38

10.45

1.2

1.3

8.74

6.29

u/ml

0.15

366

(3034770) Mitochondria Ab [Titer] in Serum

464

3362

1.39

10.38

1.2

1100.00

924.75

titre

—

120

(3017143) Hepatitis C virus Ab [Presence] in Serum

1592

13518

1.20

10.19

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

1585

13456

1.20

10.16

2.0

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

465

3385

1.39

10.12

1.2

1.3

93.17

130.77

titre

1.06

337

(3002256) Pathology report gross observation

1834

15782

1.19

10.12

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

219

1376

1.60

9.92

1.6

1.7

402.81

362.14

mu/l

0.52

175

1096

(3028308) Erythrocytes [#/volume] in Pleural fluid

174

1031

1.70

9.91

1.4

21307.04

61080.29

e6/l

3.02

561

(3045788) Cell count panel - Pleural fluid

164

958

1.72

9.84

1.5

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

324

2223

1.47

9.80

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

112

584

1.93

9.74

1.7

3.46

4.32

nmol/l

0.22

479

(1616796) Gas panel - Central venous blood

340

2363

1.45

9.63

3.2

3.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

497

3691

1.36

9.58

1.4

281.78

277.68

ug/g

0.17

303

2106

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1033

8449

1.24

9.56

2.4

16.95

22.12

au/ml

1.62

103

964

(3024666) Lithium [Moles/volume] in Serum or Plasma

118

632

1.88

9.47

14.1

13.4

0.64

0.62

mmol/l

0.39

108

575

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

441

3233

1.38

9.23

1.1

5.13

6.48

eliau/ml

0.40

419

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

958

7806

1.25

9.17

1.3

46.80

53.22

au/ml

0.34

502

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1095

9068

1.23

9.01

1.4

—

(3035880) pH of Pleural fluid

476

1.98

8.94

1.3

7.45

7.41

1.66

322

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

422

2.05

8.92

2.4

1.8

171.53

169.42

0.07

397

(3027273) Bicarbonate [Moles/volume] in Venous blood

605

4677

1.31

8.88

3.7

3.3

25.58

25.31

mmol/l

1.18

582

4527

(3036782) Glucose [Moles/volume] in Pleural fluid

159

951

1.68

8.80

1.5

1.3

6.93

6.33

mmol/l

2.26

145

888

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

109

585

1.87

8.73

1.3

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

109

585

1.87

8.73

2.3

1.8

152.85

144.27

0.48

103

551

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

652

5103

1.29

8.73

2.2

6165.94

5767.70

u/l

0.12

266

2070

(3028626) Oxygen [Partial pressure] in Capillary blood

360

2584

1.40

8.58

3.4

3.1

8.22

kpa

0.01

349

2528

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

272

1855

1.48

8.54

1.4

1.2

5.27

2.96

u/ml

1.06

124

678

(3027315) Oxygen [Partial pressure] in Blood

313

2195

1.44

8.50

3.4

3.8

8.60

kpa

0.00

307

2151

(40768806) Pleura Pathology biopsy report

167

1022

1.64

8.49

1.7

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

477

3590

1.34

8.47

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

286

1979

1.46

8.35

1.3

1.2

446.15

302.21

titre

0.40

165

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

456

3419

1.35

8.31

3.7

2.5

3.58

3.60

g/l

0.11

436

3253

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

468

3534

1.34

8.14

3.5

2.2

93.95

94.54

0.23

448

3400

(3004451) EKG impression Narrative

106

581

1.83

7.99

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

238

1604

1.49

7.96

1.3

315.55

347.46

pmol/l

0.47

206

1377

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

146

879

1.67

7.94

1.4

1.3

309.56

370.17

u/l

0.50

136

833

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

129

751

1.73

7.93

1.2

22.08

24.05

u/l

0.17

106

622

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

793

6432

1.25

7.93

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

129

752

1.72

7.90

1.5

5.76

6.67

u/l

0.37

602

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4988

46636

1.12

7.89

4.3

4.0

1.36

0.62

estimate

0.50

1217

10476

(3034274) Bile acid [Moles/volume] in Serum --fasting

251

1714

1.47

7.87

2.0

2.1

5.33

6.85

umol/l

1.39

175

1278

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

416

3105

1.35

7.83

1.2

1.3

1.34

4.81

u/ml

2.15

201

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

284

1990

1.44

7.79

1.3

1.2

63.33

175.24

titre

—

(3012501) Base excess in Blood by calculation

306

2174

1.42

7.77

3.4

3.8

2.60

2.58

mmol/l

0.03

216

1480

(46235355) HIV 1 and 2 tests - Meaningful Use set

2452

21989

1.14

7.74

2.0

1.9

—

(3013290) Carbon dioxide [Partial pressure] in Blood

306

2176

1.42

7.74

3.4

3.8

5.01

kpa

0.03

300

2133

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

294

2077

1.43

7.71

1.4

154.26

151.93

au/ml

0.13

569

(3004616) Nuclear Ab [Presence] in Serum

235

1592

1.49

7.68

1.2

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

441

3331

1.34

7.68

4.2

2.4

188.19

190.18

0.18

420

3155

(3024980) IgG subclass 4 [Mass/volume] in Serum

283

1989

1.43

7.64

1.6

0.83

0.70

g/l

1.01

219

1529

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

421

3169

1.34

7.51

1.2

3.67

4.08

0.37

450

(3003181) Sodium [Moles/volume] in Urine

305

2182

1.41

7.47

1.5

1.4

60.44

61.47

mmol/l

0.17

244

1745

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

317

2287

1.40

7.39

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

657

5264

1.26

7.33

4.7

3.9

47.38

47.60

0.08

647

5187

(3030313) Adrenal Ab [Titer] in Serum

115

2.87

7.29

1.1

26.78

23.33

titre

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

129

771

1.68

7.25

1.2

77.56

87.22

u/l

0.57

108

658

(3037121) Protein [Mass/volume] in Urine

485

3746

1.31

7.23

3.1

1022.93

421.24

mg/l

0.69

231

1499

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

314

2279

1.39

7.09

1.4

12.53

20.34

u/ml

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

449

3444

1.31

7.05

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

240

1663

1.45

7.03

1.1

174.44

7652.83

iu/ml

0.64

357

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

298

2147

1.40

7.03

2.4

72.54

84.45

ug/min

0.27

187

1244

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

242

1683

1.45

6.96

1.2

1.1

109.91

119.02

3.69

219

1519

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

279

1997

1.41

6.85

1.7

1.8

50.40

43.99

nmol/l

2.07

273

1939

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

461

3565

1.30

6.84

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

238

1656

1.45

6.83

1.1

3.11

3.27

eliau/ml

0.10

108

780

(3023183) Ammonium ion [Moles/volume] in Plasma

295

2133

1.39

6.83

2.6

2.7

31.25

33.78

umol/l

1.05

254

1931

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

115

681

1.70

6.72

1.4

1.3

10.59

14.88

u/l

1.12

101

629

(3024891) Influenza virus A+B Ag [Presence] in Specimen

395

3003

1.33

6.63

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

700

5724

1.24

6.54

3.8

3.4

1.02

ratio

1.11

629

5112

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

143

903

1.59

6.51

1.2

261.43

186.26

titre

0.35

155

(3017446) Testosterone [Moles/volume] in Serum or Plasma

633

5126

1.25

6.47

2.4

2.2

11.63

11.72

nmol/l

0.09

566

4584

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

155

1002

1.55

6.39

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

165

1082

1.53

6.38

4.1

3.1

14.17

13.43

index

0.26

107

593

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

716

5887

1.23

6.36

2.5

2.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

163

1067

1.53

6.35

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

163

1067

1.53

6.35

1.2

112.25

114.19

pmol/l

0.18

163

1067

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

178

2.36

6.35

1.5

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

144

918

1.58

6.31

2.9

2.7

23.67

27.50

mg/l

0.76

111

663

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

254

1819

1.40

6.26

1.4

1.2

4.97

3.99

u/ml

0.72

129

818

(40759836) Histone Ab [Presence] in Serum by Immunoblot

160

1047

1.53

6.25

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

305

2253

1.36

6.23

2.4

2.6

16.61

16.24

1.28

300

2209

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

396

3044

1.31

6.18

1.8

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

367

2794

1.32

6.14

1.4

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

534

1.75

6.11

1.3

1.2

153.94

148.79

mmol/24h

0.25

534

(3013139) Helicobacter pylori Ag [Presence] in Stool

1021

8721

1.19

6.08

1.3

—

(3021901) Oxygen saturation in Capillary blood

296

2187

1.36

6.05

3.0

2.9

90.34

90.13

0.24

284

2132

(3003129) Base excess in Capillary blood by calculation

177

1193

1.49

6.03

2.4

2.2

1.14

0.76

mmol/l

0.76

167

1150

(3029937) Albumin [Presence] in Urine by Test strip

3664

34065

1.11

6.03

4.5

4.3

0.00

estimate

0.22

1435

12012

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

157

1033

1.53

6.00

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

177

1198

1.48

5.92

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

186

1272

1.47

5.91

1.2

1.1

91.66

95.56

1.17

178

1194

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

250

1805

1.39

5.90

1.1

1.2

46.89

10.42

u/ml

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1031

1.52

5.86

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1050

9029

1.18

5.79

2.7

2.4

0.41

0.40

e6/l

0.04

999

8583

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

203

1418

1.44

5.78

7.5

6.5

12.13

12.17

mg/l

0.03

191

1324

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

168

1131

1.49

5.78

1.7

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

477

3792

1.27

5.76

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

650

1.65

5.75

1.1

—

(3044927) Protein electrophoresis panel - Urine

154

1020

1.52

5.73

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

377

2913

1.30

5.69

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

150

992

1.52

5.63

1.2

—

(4195642) Thrombophilia screening test

236

1702

1.39

5.63

1.2

—

(4035726) Immunohistochemistry procedure

1180

10266

1.16

5.62

1.4

—

(3012565) Volume of 24 hour Urine

556

1.70

5.60

2.0

2012.94

1899.90

0.51

505

(3028192) IgG subclass 2 [Mass/volume] in Serum

182

1254

1.46

5.59

1.5

1.4

2.96

2.85

g/l

0.41

133

896

(3024139) IgG subclass 3 [Mass/volume] in Serum

182

1255

1.46

5.57

1.5

1.4

0.34

0.39

g/l

1.88

133

895

(4062490) Immunoglobulin typing, IgG

179

1231

1.46

5.55

1.5

1.4

—

(3025941) Bacteria identified in Stool by Culture

777

6535

1.20

5.52

1.3

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

323

2460

1.32

5.44

1.6

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

256

1883

1.37

5.43

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

146

969

1.51

5.41

1.2

—

(3000494) Fungus identified in Specimen by Culture

1577

14051

1.14

5.38

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

181

1256

1.45

5.37

1.5

1.4

6.40

6.69

g/l

0.65

130

901

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

370

2886

1.29

5.24

1.4

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

627

5194

1.22

5.24

1.3

0.73

1.20

u/ml

0.69

440

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

305

2318

1.32

5.23

6.3

5.4

236.64

1586.95

iu/ml

1.12

302

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

283

2131

1.34

5.17

1.4

32.75

30.60

u/l

0.45

231

1734

(3022621) pH of Urine by Test strip

1105

9632

1.16

5.14

3.1

2.7

6.09

6.10

0.13

760

6372

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

104

648

1.61

5.10

2.2

2.1

99.49

100.69

0.10

594

(3023383) Lactate [Moles/volume] in Pleural fluid

264

1.97

5.09

1.3

2.22

3.45

mmol/l

3.15

240

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

307

2349

1.31

5.03

1.2

44.94

56.50

u/ml

0.27

(3028271) Lactate [Moles/volume] in Capillary blood

229

1678

1.37

5.01

1.8

1.58

1.67

mmol/l

0.87

221

1638

(43055442) Apixaban [Mass/volume] in Serum or Plasma

172

2.21

5.01

1.7

1.5

107.52

120.12

ug/l

0.33

153

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

256

1909

1.35

5.01

1.4

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

207

1496

1.39

4.93

1.3

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

206

2.09

4.93

1.4

1.3

69.74

75.29

mu/l

0.07

150

(3020717) Zinc [Moles/volume] in Serum or Plasma

117

757

1.55

4.91

1.4

1.5

29.97

22.93

umol/l

1.35

108

697

(3049717) Cytology report of Urine Cyto stain

418

3340

1.26

4.89

2.6

2.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

289

2203

1.32

4.88

1.3

1.2

264.11

271.93

u/ml

0.20

190

1372

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

195

1398

1.40

4.88

2.2

2.1

24.39

25.73

mg/l

0.12

512

(4024509) Urine culture

672

5647

1.20

4.86

2.1

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1508

13496

1.13

4.80

5.2

4.8

33.45

32.93

1.08

1059

8985

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

110

706

1.56

4.79

4.1

2.5

746.24

1053.25

u/ml

1.46

103

701

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

566

1.63

4.78

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

237

1763

1.35

4.74

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

185

1322

1.41

4.73

1.2

94.50

41.12

u/ml

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

331

2589

1.29

4.64

1.5

1.4

77.29

31.19

e6/l

0.65

246

1900

(3042733) HLA Ab [Presence] in Serum

309

1.85

4.63

5.0

4.8

—

(3008037) Lactate [Moles/volume] in Venous blood

324

2529

1.29

4.61

3.8

3.0

1.65

1.53

mmol/l

0.88

312

2464

(3005988) Vibrio sp identified in Specimen by Organism specific culture

197

1436

1.38

4.50

1.2

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

118

782

1.51

4.48

1.2

71.86

83.29

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1128

9950

1.15

4.48

3.2

0.76

0.77

ug/l

0.10

761

6536

(3024522) Salmonella sp identified in Specimen by Organism specific culture

205

1506

1.37

4.46

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

208

1532

1.36

4.46

1.3

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

229

1.97

4.42

1.1

1.2

299.45

327.62

pmol/l

0.15

167

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

138

947

1.46

4.42

1.4

1.3

0.59

1.59

u/ml

1.96

551

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

191

1390

1.38

4.41

1.5

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

196

1434

1.37

4.39

1.2

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1842

16769

1.12

4.38

5.7

5.5

2.40

3.07

ug/l

1.36

1617

15108

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

133

908

1.47

4.38

1.0

1.1

298.81

295.53

mg/l

0.20

124

818

(3014148) Varicella zoster virus Ab [Titer] in Serum

218

1623

1.35

4.37

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

106

2.46

4.36

1.3

17.14

22.90

0.43

(3011397) Hemoglobin [Presence] in Urine by Test strip

3089

28857

1.09

4.36

4.1

3.9

0.27

0.36

0.17

299

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

333

2630

1.27

4.34

1.6

1.4

1026.99

2767.24

e6/l

0.58

265

2063

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

213

1583

1.35

4.32

1.1

1.49

1.51

g/l

0.39

199

1432

(3016038) Potassium [Moles/volume] in Urine

117

781

1.50

4.31

1.2

31.34

33.69

mmol/l

0.59

101

664

(3045414) Leukocytes [Presence] in Urine

1296

11572

1.13

4.28

2.2

2.1

0.00

0.02

estimate

2.62

243

2366

(3017569) Oxygen content in Arterial blood

560

1.59

4.27

2.2

2.3

15.74

15.93

0.23

560

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

435

3555

1.23

4.22

2.5

2.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

186

2.05

4.17

6.4

6.9

70.52

68.36

0.19

141

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

106

699

1.52

4.15

1.5

1.3

4.38

4.70

umol/l

0.44

626

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

134

2.24

4.14

9.3

11.6

4.57

5.12

mmol/l

0.90

134

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

153

1086

1.41

4.12

1.2

1.3

—

titre

—

(3023511) Choriogonadotropin [Units/volume] in Urine

322

2551

1.27

4.12

1.4

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

402

3267

1.24

4.12

3.0

3.1

1.62

1.51

mg/l

2.02

370

2974

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

4.34

4.12

1.0

0.91

0.28

u/ml

—

(3000093) Morphology [Interpretation] in Blood Narrative

142

995

1.43

4.11

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

630

1.54

4.08

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

181

2.05

4.08

2.0

35.33

48.94

pmol/l

0.64

158

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

112

751

1.50

4.06

1.3

80.00

57.55

titre

0.40

(3025468) Yersinia sp identified in Specimen by Organism specific culture

193

1428

1.36

4.06

1.2

1.4

—

(3008295) Osmolality of Serum or Plasma

175

1277

1.38

4.02

1.5

1.4

279.72

276.95

mosm/kgh2o

0.74

126

957

(3040151) Glucose [Moles/volume] in Capillary blood

169

1228

1.38

3.98

10.5

4.5

7.93

7.49

mmol/l

0.43

143

1025

(1761482) Bacteria [#/volume] in Urine by Culture

314

2492

1.27

3.97

4.7

4.4

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

5.56

3.97

1.1

1.0

—

(40768443) Skin Pathology biopsy report

638

5442

1.18

3.96

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

185

1367

1.36

3.94

1.5

—

(3023410) Appearance of Cerebral spinal fluid

164

1192

1.38

3.87

1.7

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

112

760

1.48

3.85

1.0

1.1

—

0.54

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

498

4169

1.20

3.83

2.1

1.9

4.94

2.08

ug/l

0.47

439

3687

(3000475) Leukocytes [#/volume] in Synovial fluid

353

2856

1.24

3.80

1.8

1.6

12106.80

11982.42

e6/l

0.02

248

1994

(3026250) Tacrolimus [Mass/volume] in Blood

447

1.61

3.70

46.2

39.0

7.42

7.25

ug/l

0.29

400

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

160

1168

1.37

3.70

1.4

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

564

4793

1.18

3.68

4.3

4.7

1.62

1.61

0.06

540

4540

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

497

1.57

3.61

1.1

218.48

161.39

iu/ml

0.58

490

(42529406) Shigella sp [Presence] in Stool by Culture

396

3263

1.22

3.60

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

234

1816

1.29

3.58

1.4

17.68

14.85

u/ml

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

216

1662

1.30

3.53

1.2

1.3

67.71

58.54

u/ml

—

115

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

112

775

1.45

3.52

1.3

851.25

550.77

titre

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

256

1.80

3.52

1.3

1.1

80.45

73.02

0.47

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

140

1010

1.39

3.50

4.0

3.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

221

1708

1.30

3.50

1.1

2.46

2.72

0.14

286

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

581

1.52

3.49

1.9

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

148

1078

1.38

3.49

1.4

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

391

3233

1.22

3.45

1.2

—

(1761868) Lipid panel - Serum or Plasma

4535

43347

1.07

3.44

3.3

3.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

393

3259

1.21

3.38

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

260

1.77

3.36

1.4

1.1

85.00

82.65

0.12

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

140

2.07

3.36

1.8

1.4

12.21

10.85

0.10

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

420

1.60

3.35

2.0

29.18

28.53

0.14

402

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

151

1113

1.36

3.33

1.2

75.60

74.27

u/ml

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

9384

92020

1.08

3.29

27.5

19.9

331.05

331.42

g/l

3.99

9343

91506

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

240

1891

1.27

3.29

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

102

704

1.45

3.28

1.1

1.06

ratio

0.27

573

(3041918) Cholesterol [Moles/volume] in Pleural fluid

183

1.92

3.27

1.3

1.2

1.41

1.74

mmol/l

0.78

115

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

270

1.74

3.27

1.1

—

(3037756) Immunofixation for Serum or Plasma

275

2205

1.25

3.26

1.8

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

127

915

1.39

3.23

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

115

815

1.41

3.22

1.9

2.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

464

1.55

3.22

1.6

1.4

106.57

195.07

nmol/24h

0.64

464

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

124

891

1.40

3.21

1.5

31.20

21.91

u/ml

0.65

164

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.44

3.20

3.5

2.1

0.67

0.62

ug/l

0.32

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

3.53

3.19

1.0

0.15

0.20

u/ml

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

207

1.84

3.15

1.7

2.4

7.08

7.30

mmol/l

0.14

127

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

515

1.52

3.14

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

515

1.52

3.14

1.8

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1001

8977

1.12

3.13

1.6

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

264

2119

1.25

3.12

1.3

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.54

3.12

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

492

1.53

3.11

3.2

2.9

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

737

6487

1.14

3.10

5.8

6.7

24.48

24.62

mmol/l

0.46

703

6210

(4094501) Cardiovascular stress test using bicycle ergometer

356

2955

1.21

3.07

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

454

1.54

3.06

2.4

2.0

130.33

103.60

ug/min

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

358

2977

1.21

3.03

1.5

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.75

2.98

1.4

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

126

921

1.37

2.97

1.4

1.3

2.31

2.06

mmol/l

1.01

118

862

(3034426) Prothrombin time (PT)

363

1.60

2.96

1.3

1.2

28.23

28.06

0.08

363

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

508

1.50

2.91

2.1

2.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

183

1418

1.29

2.91

2.0

1.9

188.34

188.46

pmol/l

0.00

163

1335

(3006571) Granulocytes/Leukocytes in Synovial fluid

171

1313

1.31

2.91

1.7

1.6

56.73

55.02

0.21

107

798

(3005532) Lymphocytes/Leukocytes in Pleural fluid

311

1.64

2.89

1.7

1.4

71.86

63.52

1.08

264

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1385

12701

1.10

2.88

1.7

1.41

1.42

0.19

1200

11191

(3028433) Virus identified in Specimen by Culture

350

1.60

2.88

1.1

1.2

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

3.71

2.87

1.0

0.05

0.36

u/ml

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

675

1.43

2.85

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

157

1.91

2.83

1.4

1.2

1.23

1.81

mmol/l

0.31

106

(3022475) Manganese [Moles/volume] in Blood

2.34

2.81

1.2

0.16

umol/l

0.19

(3006653) Thiamine [Moles/volume] in Blood

596

1.45

2.77

1.1

1.3

131.53

134.02

nmol/l

0.19

596

(3016750) Collection duration of Urine

514

1.48

2.77

1.8

2.3

496.35

498.66

min

0.08

391

(3020491) Glucose [Moles/volume] in Blood

109

789

1.38

2.76

1.8

6.66

6.55

mmol/l

0.19

569

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

553

4814

1.16

2.75

1.6

12.04

17.00

u/ml

1.29

104

1109

(3007930) Methemoglobin/Hemoglobin.total in Blood

507

4386

1.16

2.75

4.6

5.0

0.86

0.88

0.57

486

4145

(3036005) Urine sediment comments by Light microscopy Narrative

8.34

2.75

1.2

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

131

978

1.34

2.73

1.7

—

(3008898) HLA-B27 [Presence]

501

4336

1.16

2.70

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.14

2.70

1.3

1.2

0.05

0.57

u/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

114

835

1.37

2.69

1.3

1.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

223

1791

1.25

2.68

3.6

1.19

1.60

1.12

203

1619

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

356

2998

1.19

2.68

1.4

1.3

614.61

520.78

mg/l

0.71

340

2877

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1451

13387

1.09

2.67

4.3

4.5

22.99

21.97

1.41

672

6549

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

228

1837

1.25

2.67

2.5

2.6

312.67

1726.82

u/ml

1.52

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

176

1.82

2.62

1.2

1.3

36.61

39.98

mg/l

0.17

150

(3006245) CD3-CD19+ cells/cells in Blood

440

1.50

2.60

2.0

2.2

9.69

9.25

0.13

415

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

104

756

1.38

2.59

2.3

2.4

482.37

521.85

e6/l

0.37

599

(3023419) Bacteria identified in Sputum by Culture

175

1373

1.28

2.57

2.7

—

(21494755) Public health laboratory ask at order entry panel

930

10268

0.90

2.57

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

107

2.06

2.56

1.1

2.42

1.78

iu/ml

0.83

(3025130) Human papilloma virus identified in Specimen

285

2368

1.21

2.50

1.8

—

(3000060) B lymphocytes [#/volume] in Blood

324

1.58

2.50

1.9

2.0

0.20

0.21

e9/l

0.05

146

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

317

2662

1.20

2.49

1.3

1.2

3.89

3.68

mmol/l

2.37

305

2524

(3011412) CD3 cells [#/volume] in Blood

140

1072

1.31

2.49

2.2

2.4

1224.78

1222.08

e6/l

0.01

120

936

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

249

2044

1.22

2.47

2.3

2.0

0.93

0.86

nmol/l

0.72

206

1738

(3008757) Leukocyte morphology finding [Identifier] in Blood

140

1073

1.31

2.47

3.6

3.7

—

(3038515) Glucose [Moles/volume] in Venous blood

255

2103

1.22

2.43

4.3

3.2

7.51

7.50

mmol/l

0.02

247

2051

(21494890) Protein electrophoresis panel - 24 hour Urine

134

1024

1.31

2.42

1.7

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1304

12030

1.09

2.42

3.4

4.1

22.60

23.18

ug/l

0.01

1034

9589

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

105

775

1.36

2.40

2.4

2.6

210.56

220.20

e6/l

0.27

654

(3001893) Eosinophils/Leukocytes in Pleural fluid

265

1.62

2.40

1.7

1.5

3.60

2.41

0.30

227

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.11

2.38

1.2

1.3

81.57

107.94

ug/l

0.35

(37208534) Antinuclear antibody arbitrary concentration in serum

385

1.51

2.36

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

338

1.54

2.33

2.8

3.1

—

(3004775) Volume in Urine collected for unspecified duration

694

1.37

2.33

2.0

2.4

623.36

631.03

0.07

475

(3052592) Norovirus Ag [Presence] in Stool

191

1.73

2.32

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

122

927

1.32

2.32

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

122

927

1.32

2.32

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

122

927

1.32

2.32

1.4

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

115

867

1.33

2.31

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

693

6205

1.12

2.31

1.6

940.69

1007.24

mu/l

1.05

562

5196

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

552

1.42

2.30

1.1

11.80

15.44

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

162

1.79

2.30

1.0

1.1

—

(4268621) Lupus anticoagulant assay

167

1324

1.26

2.30

2.6

2.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

159

1254

1.27

2.28

2.3

2.4

1.02

1.20

g/24h

0.59

695

(3045683) HLA typing for celiac disease panel - Blood or Tissue

101

748

1.35

2.28

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

660

5897

1.13

2.28

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

299

2521

1.19

2.28

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

466

4072

1.15

2.27

3.0

3.4

203.08

2005.42

u/ml

1.85

394

3470

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

631

1.38

2.24

1.3

1.4

257.13

1682.46

pmol/l

—

(3006270) Folate [Moles/volume] in Blood

118

898

1.32

2.23

1.2

376.03

368.67

nmol/l

0.14

776

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

219

1799

1.22

2.20

1.3

1.2

40.13

32.70

u/l

0.20

201

1563

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

408

1.47

2.20

1.2

102.80

111.79

0.77

368

(3027231) Wheat IgE Ab [Units/volume] in Serum

225

1.65

2.20

1.0

0.36

2.15

u/ml

0.88

192

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

162

1289

1.26

2.18

2.5

35.64

27.72

iu/ml

0.26

134

(3044242) Glucose [Moles/volume] in Arterial blood

576

1.39

2.16

1.9

2.0

9.82

7.82

mmol/l

1.49

576

(44790048) Parainfluenza type 2 nucleic acid detection

174

1398

1.25

2.16

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

174

1398

1.25

2.16

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

174

1398

1.25

2.16

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

174

1398

1.25

2.16

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

101

756

1.34

2.15

1.0

1.1

0.70

1.62

u/ml

0.91

238

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

113

860

1.32

2.15

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

101

1.98

2.14

1.2

1.1

18.40

22.98

u/l

0.67

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

137

1072

1.28

2.12

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

396

1.47

2.10

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

190

1.69

2.09

1.1

1.0

76.49

75.46

ug/l

0.04

155

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

160

1280

1.25

2.07

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

565

1.38

2.05

1.3

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

565

1.38

2.05

1.3

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

565

1.38

2.05

1.3

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

146

1.78

2.05

1.2

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

202

1660

1.22

2.05

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

597

5341

1.12

2.05

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

199

1633

1.22

2.05

1.2

1.1

0.88

1.10

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

567

1.38

2.02

1.3

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

393

1.45

1.98

1.1

1.2

81.36

91.40

0.71

169

(3017704) Immunofixation for Urine

510

1.39

1.98

2.1

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

265

2246

1.18

1.95

1.5

1.4

0.41

0.43

nmol/l

0.21

199

1688

(3019832) Treponema pallidum Ab [Presence] in Serum

1311

12218

1.08

1.95

1.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

132

1044

1.27

1.91

1.3

1.54

1.51

nmol/l

0.12

116

937

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

135

1.78

1.90

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

140

1118

1.26

1.88

1.2

1.3

—

(3020891) Body temperature

557

4993

1.12

1.88

4.5

4.4

36.94

36.91

°c

1.51

550

4946

(3003740) Influenza virus B Ag [Presence] in Specimen

245

2071

1.19

1.88

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.20

1.84

2.2

1.7

0.99

0.79

umol/l

0.54

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

160

1.69

1.81

1.3

1.2

4.70

4.85

nmol/l

0.07

154

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

254

1.54

1.80

1.2

1.3

13.10

247.87

ug/l

1.62

136

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

511

1.37

1.80

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

511

1.37

1.80

1.4

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

554

1.36

1.79

1.2

11.93

10.54

mm/h

0.36

554

(40757494) Bilirubin.total [Moles/volume] in Blood

512

1.37

1.78

2.2

14.86

18.29

umol/l

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

394

1.42

1.78

1.3

2.0

376.40

56262.92

u/ml

—

(3047181) Lactate [Moles/volume] in Blood

364

3189

1.15

1.78

4.6

5.4

1.27

1.31

mmol/l

0.40

323

2830

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

584

0.67

1.78

22.0

13.7

877.13

3016.62

nmol/l

0.48

565

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

435

3858

1.13

1.77

1.6

1.5

0.20

7.62

iu/ml

0.89

730

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

530

1.36

1.77

1.4

2.1

103.64

134.90

umol/l

0.44

287

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

479

1.38

1.76

1.1

832.85

381.87

ng/l

0.27

128

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

121

960

1.26

1.74

1.1

12.50

8.40

iu/ml

0.61

254

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

473

4222

1.13

1.74

2.4

1.7

4.66

4.29

mg/l

0.31

384

3144

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

330

1.46

1.73

1.1

1.3

135.21

125.77

nmol/l

0.17

229

(3002523) Influenza virus A Ag [Presence] in Specimen

243

2071

1.18

1.72

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

155

1268

1.23

1.70

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

433

1.39

1.67

28.4

28.7

115.81

113.96

ug/l

0.08

352

(3014891) Appearance of Pleural fluid

126

1.75

1.67

1.7

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

251

2151

1.17

1.67

1.3

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

493

4425

1.12

1.66

1.4

1.6

0.26

0.29

mg/l

0.62

185

1938

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

245

2097

1.17

1.66

1.2

1.1

11.77

14.89

au/ml

0.35

515

(3026389) Candida sp identified in Specimen by Organism specific culture

232

1978

1.18

1.65

1.3

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

142

1156

1.23

1.65

3.4

3.6

57.21

56.66

0.11

128

997

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

410

1.39

1.63

1.2

112.29

110.13

0.29

366

(1175426) CD3 cells/Lymphocytes in Blood

110

871

1.27

1.63

1.9

2.1

73.64

73.61

0.01

101

836

(40765096) Chromosome analysis panel by Banding

315

0.57

1.61

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

173

1441

1.20

1.61

5.4

5.5

371.76

362.45

umol/l

0.43

142

1265

(3003329) Lymphocytes/Leukocytes in Synovial fluid

122

980

1.25

1.60

1.7

1.5

28.83

33.53

0.68

562

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

105

829

1.27

1.60

1.9

2.1

14.00

14.81

0.42

810

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

121

972

1.25

1.59

2.7

2.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

637

1.30

1.57

1.3

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

373

3307

1.13

1.56

1.4

1.5

—

(3045424) Erythrocytes [Presence] in Urine

641

5858

1.10

1.55

2.1

2.2

0.03

0.18

estimate

0.57

194

1893

(3050129) First trimester maternal screen panel - Serum or Plasma

460

4132

1.12

1.55

1.5

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.88

1.54

1.1

1.2

0.72

0.53

iu/ml

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

373

1.40

1.53

2.8

2.7

0.60

0.61

mmol/l

0.60

373

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

153

1.64

1.52

1.3

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

241

1.50

1.51

1.1

0.53

0.65

umol/24h

1.38

109

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

106

846

1.26

1.49

1.1

18.90

18.02

u/ml

0.11

350

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

564

1.31

1.49

1.3

1.2

55.90

68.68

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

333

3761

0.88

1.48

1.1

0.58

0.60

ratio

0.30

478

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

243

1.48

1.46

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

155

1.61

1.46

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

112

903

1.24

1.45

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.88

1.44

1.1

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.97

1.43

1.0

1.3

—

(44806420) Estimation of glomerular filtration rate

167

1405

1.19

1.43

2.5

2.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

709

1.27

1.43

1.7

1.5

6.16

5.96

u/l

0.10

614

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

376

3358

1.12

1.43

1.4

1.5

1.17

1.21

ratio

0.38

232

2064

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

376

3358

1.12

1.43

1.4

1.5

0.93

0.95

ratio

0.62

228

2052

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

864

9283

0.93

1.42

1.7

1.6

3.49

3.48

mmol/l

0.06

601

6293

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

104

834

1.25

1.42

1.6

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

375

3350

1.12

1.42

1.4

1.5

1.11

1.15

ratio

0.45

227

2043

(3042631) Mycobacterium sp identified in Specimen

163

1370

1.19

1.41

2.2

2.8

—

(3024471) HLA-A [Type]

295

1.43

1.41

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

440

1.34

1.39

1.2

0.31

0.30

g/l

0.21

353

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

150

1253

1.20

1.39

1.1

—

4.63

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

197

1.52

1.39

1.3

1.4

18.84

23.74

0.61

169

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

492

1.32

1.39

1.0

92.71

93.32

0.07

388

(3024932) HLA-DR beta [Type]

288

1.42

1.38

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

424

1.35

1.37

1.4

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

417

1.34

1.4

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

417

1.34

1.4

1.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

400

1.35

1.34

1.1

85.71

91.68

0.49

166

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

151

1.59

1.34

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1283

12133

1.06

1.33

2.1

2.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

882

8235

1.08

1.33

3.4

3.7

67.66

63.06

u/ml

0.09

851

7965

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

204

1759

1.16

1.32

1.6

1.5

—

(4015189) Microbial culture of sputum

249

1.45

1.32

2.1

2.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.78

1.28

1.0

2.9

1.70

1.86

mu/l

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

133

0.45

1.27

2.2

1.9

1.63

1.58

mg/l

—

113

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.94

1.27

1.3

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

153

1294

1.18

1.27

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

393

3549

1.11

1.26

1.5

62.01

61.15

ug/l

0.12

322

2956

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

117

0.43

1.24

1.2

1.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.40

1.24

1.0

1.2

3.00

2.96

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

363

1.35

1.24

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.16

1.21

1.3

1.1

28.63

34.74

umol/24h

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

727

1.24

1.20

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

341

1.35

1.17

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

125

1.60

1.17

3.0

2.7

0.75

0.72

u/field

0.04

125

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

133

1.58

1.17

1.4

1.3

26.42

275.46

u/l

0.58

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1407

13405

1.06

1.16

2.2

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

741

1.23

1.14

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

723

1.23

1.14

1.4

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

108

896

1.21

1.13

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

198

1729

1.15

1.13

1.5

1.6

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.33

1.12

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.00

1.12

3.6

9.3

99.50

105.42

g/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

111

1.62

1.11

1.1

1.2

1.50

1.62

umol/24h

0.34

111

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

1.62

1.11

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

134

1137

1.18

1.11

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

718

1.23

1.09

1.8

1.6

13.49

8.03

ug/l

0.58

649

(3006462) Nitrate [Presence] in Urine

530

1.27

1.09

2.8

3.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

168

1.49

1.09

1.3

1.4

0.27

0.28

nmol/l

0.06

115

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

152

1.51

1.08

1.3

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

287

1.36

1.06

1.1

1.4

—

(3002619) Bacteria identified in Specimen by Culture

296

1.35

1.05

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

129

1.55

1.05

1.3

1.6

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

375

1.31

1.04

1.2

1.3

35.43

21.26

—

(4211845) Urine protein measurement

579

1.24

1.03

3.1

3.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.27

1.03

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

178

0.56

1.03

4.2

5.8

9.51

8.38

mmol/l

—

178

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

607

1.24

1.02

1.3

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

188

1.44

1.01

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

636

1.23

1.00

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1184

12417

0.95

0.99

1.9

3.44

3.36

ratio

0.83

910

9374

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

467

1.26

0.98

1.2

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.97

0.0

1.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

4.7

—

5.10

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

739

1.21

0.96

1.0

6.03

1.06

u/ml

0.42

175

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

594

1.23

0.96

2.3

2.8

42.61

41.25

0.31

343

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

371

1.29

0.96

1.1

—

(40762814) Titanium [Mass/volume] in Blood

165

1.46

0.96

2.9

2.4

6.79

3.70

ug/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

108

1.57

0.96

2.9

2.6

—

(3033099) Centromere Ab [Titer] in Serum

310

1.32

0.96

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

470

1.26

0.94

1.5

1.7

6151.11

3129.41

titre

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

133

1.50

0.94

1.6

2.0

1.28

1.35

umol/l

0.39

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

166

1.45

0.94

1.9

2.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.22

0.93

3.0

1.9

272.33

260.01

ug/l

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.22

0.93

1.3

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

371

3407

1.09

0.92

3.6

3.9

1.32

1.35

mmol/l

0.33

364

3346

(40757373) Influenza virus identified in Isolate

201

1.39

0.91

1.7

1.6

—

(4146454) Self-monitoring of blood glucose

129

1115

1.16

0.90

3.2

2.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

673

1.20

0.89

1.3

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

102

0.49

0.89

2.4

3.1

36.20

45.48

—

102

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

102

0.49

0.89

4.8

6.3

7.00

7.91

—

102

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

155

1359

1.14

0.89

2.0

2.1

31.81

32.35

1.03

155

1347

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

403

1.27

0.88

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

237

2135

1.11

0.88

1.1

0.59

0.92

u/ml

1.18

102

898

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

396

1.26

0.86

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

246

2226

1.11

0.85

1.1

3.54

4.39

u/ml

0.58

140

1153

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

559

1.22

0.84

2.4

1.8

1.13

2.64

u/field

2.49

392

(3039000) Anion gap in Blood by calculation

238

2151

1.11

0.84

5.4

6.5

11.81

11.21

mmol/l

1.64

218

1927

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

203

0.64

0.84

1.1

1.0

0.13

0.62

u/ml

—

130

(3018572) Chloride [Moles/volume] in Blood

238

2152

1.11

0.83

5.4

6.5

104.69

105.05

mmol/l

0.53

218

1929

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

206

1849

1.12

0.83

1.3

1.4

2.42

3.61

ug/l

2.89

176

1616

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

188

1.38

0.82

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

188

1.38

0.82

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

188

1.38

0.82

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.74

0.82

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

526

1.22

0.80

1.7

1.5

3.71

3.44

0.06

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.70

0.80

1.3

1.0

—

(21494815) CD4 cells/Lymphocytes in Specimen

107

924

1.16

0.78

2.0

2.2

40.62

41.05

0.10

102

904

(3027035) Albumin [Mass/time] in 24 hour Urine

0.52

0.78

1.2

1.3

—

577.53

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

110

953

1.16

0.77

1.2

40.32

40.26

mg/l

0.00

815

(3051387) C reactive protein [Mass/volume] in Capillary blood

248

2260

1.10

0.77

4.2

3.5

23.47

25.69

mg/l

0.46

166

1568

(40761539) Cells [Type] in Urine sediment by Light microscopy

252

1.31

0.76

1.2

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

132

1.44

0.75

1.2

9.47

6.26

mmol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

279

1.29

0.75

1.8

1.7

—

(3048879) Bone marrow aspiration report

277

0.72

1.4

1.9

—

2.00

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.80

0.72

1.0

1.1

194.29

275.18

nmol/l

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.62

0.71

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

590

1.19

0.70

1.2

1.1

—

(3019174) dRVVT (LA screen)

101

1.49

0.70

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

256

1.29

0.69

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

186

1.34

0.69

5.6

7.5

5.46

5.45

kpa

0.01

186

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

693

1.17

0.69

1.9

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

574

1.19

0.68

2.0

1.9

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.59

0.68

1.1

1.0

—

(44806071) Cardiolipin IgM antibody measurement

161

1.37

0.68

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

117

0.60

0.67

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

102

1.47

0.67

1.9

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

170

1.35

0.67

1.1

1.2

61.83

63.25

ug/l

0.19

170

(4133840) Spirometry

249

0.72

0.66

1.4

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

385

3605

1.07

0.65

2.1

1.8

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

250

1.28

0.65

1.2

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.57

0.65

5.2

5.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.61

0.65

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

634

1.17

0.64

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

225

2066

1.09

0.63

1.1

2.26

1.23

u/ml

0.76

113

1010

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.59

0.61

1.6

1.5

364.90

300.90

umol/24h

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.67

0.61

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

1.67

0.61

1.2

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.60

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

417

1.20

0.59

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.53

0.59

1.4

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

603

1.16

0.58

1.7

2.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

866

1.13

0.57

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

106

1.42

0.57

1.8

3.0

3.02

1.04

mg/l

—

(40768446) Kidney Pathology biopsy report

392

1.20

0.56

1.6

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

503

1.17

0.56

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.45

0.56

8.0

4.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.45

0.56

1.4

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

317

2970

1.07

0.56

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

338

1.21

0.55

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

276

2574

1.07

0.55

1.1

1.83

1.92

u/ml

0.06

141

1337

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.62

0.55

3.3

3.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

440

4167

1.06

0.55

1.4

1.3

214.64

227.63

miu/ml

0.32

208

1976

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

284

1.23

0.55

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

785

1.13

0.54

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

477

1.17

0.54

1.3

1.2

1308.33

955.79

titre

0.78

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.58

0.54

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.49

0.53

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

134

1.34

0.52

1.3

—

(3019150) Specific gravity of Urine by Refractometry

2792

27414

1.02

0.52

4.6

4.2

1.02

1.18

kg/l

1.08

1933

18042

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

452

4756

0.95

0.52

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

201

1860

1.08

0.51

2.3

2.6

—

(3001556) Androgen free Index in Serum or Plasma

1.41

0.50

1.8

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

612

1.14

0.50

1.6

1.22

1.31

nmol/l

0.29

461

(3045142) Bone marrow Pathology biopsy report

131

1190

1.10

0.50

1.1

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

716

1.13

0.49

1.3

1.2

0.71

0.61

ratio

0.49

418

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.49

0.49

1.2

1.1

8.64

8.01

mmol/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

180

1.28

0.49

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

252

1.23

0.49

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.43

0.49

3.5

2.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

718

1.13

0.48

1.2

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

172

1.28

0.48

1.1

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

308

1.20

0.47

1.0

1.1

0.29

1.72

u/ml

1.43

172

(3039744) RNA polymerase III Ab [Units/volume] in Serum

102

1.37

0.47

1.1

1.0

—

6.08

—

(3000012) Reticulocyte production index

159

1464

1.09

0.47

1.9

2.1

0.93

0.92

0.14

101

971

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

905

8760

1.04

0.47

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

514

1.15

0.46

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

155

1428

1.09

0.45

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

246

1.22

0.45

1.1

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

468

1.15

0.45

3.4

3.5

1.39

1.30

0.12

468

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.40

0.45

1.4

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

386

1.17

0.43

1.3

159.46

173.37

pmol/l

0.18

386

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

157

1.27

0.43

2.5

1.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.41

0.43

1.1

29.45

9.41

u/l

0.38

(3001964) Herpes simplex virus Ag [Presence] in Specimen

322

1.18

0.42

1.8

1.5

—

(3024263) Appearance of Synovial fluid

537

1.14

0.42

2.6

1.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

286

1.19

0.41

3.0

3.5

68.69

113.81

ng/l

0.93

112

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

105

1.33

0.41

1.3

1.1

130.29

89.60

titre

0.92

105

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

102

928

1.10

0.41

1.1

250.74

246.55

mg/l

0.08

832

(3013166) Neutrophils/Leukocytes in Synovial fluid

314

0.83

0.39

1.2

1.4

63.93

53.23

0.75

264

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

269

1.19

0.39

1.1

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

196

1.22

0.39

1.5

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

344

1.16

0.38

3.2

3.6

5.15

4.99

kpa

0.44

344

(40758292) HTLV I+II Ab panel - Serum

203

0.79

0.37

1.1

1.3

—

(4034850) Laboratory test

334

3500

0.95

0.37

12.3

9.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

345

1.16

0.37

3.2

3.6

9.98

10.40

kpa

0.44

345

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

269

2553

1.05

0.37

3.3

3.8

37.58

38.11

u/ml

0.01

264

2470

(40768795) Lymph node Pathology biopsy report

129

1194

1.08

0.37

1.1

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

143

1.26

0.36

3.5

6.0

20.92

40.89

ug/min

2.95

107

(3000034) Microalbumin [Mass/volume] in Urine

907

1.09

0.36

2.5

2.9

23.37

46.19

mg/l

1.19

647

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

213

2010

1.06

0.36

1.8

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.37

0.34

1.1

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

298

2844

1.05

0.34

1.5

1.6

—

(40768793) Breast Pathology biopsy report

382

3670

1.04

0.33

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

941

9182

1.03

0.33

2.9

2.7

64.64

67.46

ml/min/173m2

1.44

443

3881

(3005033) Fetal Nuchal fold Thickness US

286

2730

1.05

0.33

1.5

1.22

1.25

0.63

199

1992

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

155

0.77

0.33

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.30

0.33

1.0

1.3

—

(3047189) Immunofixation for 24 hour Urine

463

1.12

0.33

1.9

1.8

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.28

0.32

1.2

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

731

1.09

0.32

3.2

3.4

24.33

25.98

mu/l

0.19

695

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.33

0.32

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

351

1.14

0.31

2.3

2.6

164.03

109.85

au/ml

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.35

0.31

1.0

1.2

274.86

359.00

u/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

456

1.12

0.31

2.2

2.4

48.93

51.23

umol/l

0.24

399

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

638

1.10

0.30

1.1

1483.41

1551.19

miu/ml

0.22

638

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

232

2211

1.05

0.30

1.5

65.98

58.99

ug/l

1.36

232

2211

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

120

1.25

0.30

1.3

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

175

1.20

0.30

1.0

1.1

19.12

6.67

u/ml

0.66

175

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.29

0.30

1.5

1.6

0.51

2.15

mg/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

918

1.08

0.29

1.6

7.72

7.81

mmol/l

0.14

880

(3008536) Aspergillus sp Ab [Presence] in Serum

222

1.17

0.29

1.2

2.1

—

(3050794) Legionella sp Ab [Presence] in Serum

106

0.75

0.29

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

288

1.15

0.28

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

214

2039

1.05

0.28

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

121

1.24

0.28

1.3

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.29

0.28

1.5

559.23

536.34

nmol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

289

1.14

0.27

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

681

1.09

0.27

1.1

1.23

1.14

u/l

0.27

279

(3047352) Trisomy 18 risk [Likelihood] in Fetus

289

2779

1.04

0.27

1.5

—

(21494434) Karyotype in Bone marrow

904

1.07

0.26

1.1

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

215

1.16

0.26

1.2

58.36

69.77

ug/l

0.74

215

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

452

1.11

0.26

1.4

1.9

40.68

40.17

g/l

0.29

452

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

166

1576

1.05

0.26

1.0

1.1

0.19

0.28

u/ml

0.42

491

(4212803) Bone marrow aspirate examination

1.26

0.26

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

338

1.12

0.26

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

338

1.12

0.26

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

338

1.12

0.26

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

338

1.12

0.26

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

345

3332

1.04

0.26

1.9

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

732

7153

1.02

0.26

1.9

1.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

1.21

0.25

1.2

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

360

3482

1.03

0.25

1.4

1.5

184.99

149.62

pmol/l

0.28

352

3390

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

256

0.86

0.25

2.4

2.0

19.78

16.26

umol/l

0.73

256

(3010144) Erythrocytes [#/volume] in Synovial fluid

113

1062

1.06

0.25

1.4

117865.34

118164.47

e6/l

0.00

709

(3014133) Dog dander IgE Ab [Units/volume] in Serum

194

1853

1.05

0.25

1.1

2.47

3.68

u/ml

0.84

890

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

550

1.09

0.25

1.3

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.18

0.24

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

283

1.13

0.24

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

275

0.87

0.23

1.7

1.3

46.13

39.66

0.38

184

(3023487) Leukocytes [#/volume] in Peritoneal fluid

390

0.90

0.22

1.7

2.0

845.91

4238.40

e6/l

0.76

256

(3007463) Buprenorphine [Presence] in Urine

1.25

0.22

3.0

4.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

125

1.20

0.22

1.0

1.1

0.02

0.05

u/ml

1.45

125

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.22

0.22

1.0

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

2.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

101

0.79

0.21

1.0

—

(3016879) Cocaine [Presence] in Urine

406

3953

1.03

0.21

1.8

2.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

126

1.19

0.21

1.1

1.0

0.12

0.67

u/ml

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

219

0.87

0.20

1.6

2.3

10.68

169.09

ug/l

0.65

219

(3036670) Protein [Mass/volume] in Synovial fluid

345

1.10

0.20

1.2

1.3

41.47

38.91

g/l

0.59

168

(4198724) Urine methamphetamine measurement

438

0.91

0.20

1.6

2.8

—

(3017509) Phencyclidine [Presence] in Urine

115

0.78

0.20

1.4

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

385

1.09

0.19

2.5

3.0

31.37

28.28

umol/l

0.92

288

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

249

2412

1.03

0.18

2.8

3.5

826.46

508.59

u/ml

0.31

224

2180

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

143

0.84

0.18

1.3

1.4

44.50

58.03

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

785

1.06

0.17

1.2

1.5

1.18

1.17

promille

0.04

616

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.13

0.17

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

339

1.09

0.17

1.7

1.5

0.52

0.50

e9/l

0.19

339

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.72

0.16

1.2

1.0

6.02

13.83

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

158

1.14

0.16

1.8

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.13

0.16

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

886

1.05

0.16

2.3

2.0

1.96

1.80

u/field

0.18

468

(3020393) Adenovirus Ag [Presence] in Stool

102

1.18

0.15

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

309

3018

1.02

0.15

2.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.80

0.14

1.6

2.3

—

(3001729) Color of Synovial fluid

0.78

0.14

1.3

1.6

—

(4281824) Cell count and differential, peritoneal fluid

155

1601

0.97

0.14

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.19

0.14

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

167

1722

0.97

0.13

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

521

0.94

0.13

1.9

1.7

1.26

2.00

u/ml

0.59

128

(3018851) Theophylline [Moles/volume] in Serum or Plasma

100

0.80

0.13

2.5

1.5

62.50

46.53

umol/l

—

100

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

149

0.87

0.13

2.8

1.4

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

151

1.13

0.13

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

745

1.05

0.13

1.3

1.5

28.20

36.18

nmol/l

1.60

678

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

159

0.88

0.13

1.1

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

181

1760

1.03

0.13

1.1

2.65

3.91

u/ml

0.59

763

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

386

0.93

0.12

1.1

1.0

6.89

11.06

u/ml

0.77

252

(3037692) Legionella sp identified in Specimen by Organism specific culture

384

1.07

0.12

1.6

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

148

0.88

0.12

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

104

1.15

0.12

1.0

—

(3044007) Cell count panel - Peritoneal fluid

334

0.93

0.12

1.7

1.9

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

181

1.11

0.12

1.4

1.6

—

(40768800) Prostate Pathology biopsy report

104

1075

0.97

0.11

1.2

—

(44813793) Dust mix specific IgE antibody measurement

882

0.96

0.10

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

554

1.05

0.10

1.1

4.94

7.32

u/ml

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

290

0.93

0.10

2.2

1.9

2.52

3.41

ug/l

0.24

172

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

125

0.88

0.10

1.5

3.5

38.27

39.99

umol/l

0.10

109

(3032352) Blasts [#/volume] in Cerebral spinal fluid

125

1.12

0.10

2.4

2.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.11

0.09

1.0

—

(3020650) Glucose [Presence] in Urine

422

0.95

0.09

1.5

1.7

0.00

0.03

estimate

1.34

422

(3018001) Oat IgE Ab [Units/volume] in Serum

1.15

0.09

1.0

0.06

0.22

u/ml

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

155

1.10

0.09

1.4

1.2

401.13

66.74

ng/l

0.41

(40765089) Chromosome analysis panel - Blood by G-banded

288

0.94

0.08

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

907

0.97

0.08

1.5

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

109

1119

0.97

0.08

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

0.78

0.08

2.6

1.4

150.00

169.25

ug/g

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.77

0.08

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.09

0.08

1.0

—

(3011048) Pyruvate [Moles/volume] in Blood

1.06

0.08

1.1

1.3

73.00

80.46

umol/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

688

1.03

0.07

1.0

0.18

0.79

u/ml

0.69

165

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.04

0.07

1.0

1.1

1.25

1.31

mom

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

718

1.03

0.07

1.0

33.39

42.63

ng/l

1.76

508

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

118

1.10

0.07

1.0

—

(40768441) Liver Pathology biopsy report

867

1.03

0.07

1.3

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

868

1.03

0.06

1.7

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

138

1.09

0.06

1.3

1.2

5.75

5.82

mmol/l

0.09

138

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

109

1.10

0.06

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

674

1.02

0.04

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

140

1.07

0.04

6.9

7.0

11.76

10.36

1.17

140

(3000764) Benzodiazepines [Presence] in Urine

432

4291

1.01

0.04

1.8

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

493

0.97

0.04

3.7

4.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

281

0.96

0.04

1.3

1.4

15.51

13.09

g/l

0.72

215

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

716

1.02

0.03

1.0

646.14

738.33

ng/l

1.26

504

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1278

12818

1.00

0.03

7.7

6.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

280

0.96

0.03

1.5

1.7

147.04

106.90

au/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

858

1.01

0.02

1.1

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

470

1.02

0.02

4.5

5.4

3072.50

8830.44

u/ml

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

218

0.96

0.02

1.3

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

153

1542

0.99

0.02

4.6

4.3

82.94

63.06

u/ml

0.38

148

1526

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

159

1578

1.01

0.02

1.4

1.3

6.92

7.19

mmol/l

0.67

141

1400

(3032057) Clostridioides difficile [Presence] in Stool

238

0.97

0.02

1.5

1.8

—

(3036048) Francisella tularensis Ab [Titer] in Serum

248

0.97

0.02

1.1

—

190.77

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

549

0.98

0.02

1.5

—

2210440.84

iu/ml

—

(3042517) Benzodiazepines panel - Urine

117

0.94

0.01

3.1

2.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

203

1.03

0.01

1.8

1.6

—

(3025577) Chromium [Mass/volume] in Blood

578

0.99

0.01

2.4

2.3

2.67

2.59

ug/l

0.05

492

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

712

1.01

0.01

1.0

252.11

336.78

ng/l

2.13

513

(3027944) Amphetamines [Presence] in Urine

427

4262

1.00

0.00

1.8

1.9

—

(3027008) Opiates [Presence] in Urine

432

4312

1.00

0.00

1.8

1.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

264

1.02

0.00

1.1

22.48

31.84

iu/ml

0.71

264

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

326

0.98

0.00

1.8

1.7

9.20

8.90

ug/l

0.13

326

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

336

0.98

0.00

1.4

1.8

8102.38

18732.05

e6/l

0.70

168

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

384

1.02

0.00

3.0

3.5

8.11

8.51

mg/l

0.14

308

(3045462) Protein/Creatinine [Ratio] in Urine

103

0.97

0.00

3.6

2.7

48.73

33.21

mg/mmol

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

103

0.97

0.00

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

145

1.03

0.00

2.1

2.5

1.88

1.06

mmol/l

—

101

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

165

1.03

0.00

1.1

1.0

0.01

0.19

u/ml

0.58

103

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

235

0.98

0.00

1.7

1.3

1.19

1.18

mmol/l

0.28

235

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

385

1.01

0.00

1.8

2.0

9.26

9.20

mg/l

0.02

328

(3028300) Cannabinoids [Presence] in Urine

433

4326

1.00

0.00

1.8

2.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

198

1.01

0.00

1.3

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

101

0.99

0.00

1.1

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

225.50

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

30.35

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.93

0.00

1.0

1.1

0.03

0.04

u/ml

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

14.00

—

(3046861) Legionella sp Ag [Presence] in Urine

1.00

-0.00

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.2

—

12.50

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.02

-0.00

1.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

450

1.00

-0.00

1.8

2.2

25.36

30.76

1.90

450

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

41.50

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

0.95

-0.00

2.5

499.88

401.19

umol/l

—

(3010937) Rubella virus Ab [Presence] in Serum

0.96

-0.00

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

290

1.00

-0.00

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.89

-0.00

1.8

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.97

-0.00

3.9

5.8

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

25.71

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.85

-0.00

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint THYROTOXICOSIS and mortality.

Females

Parameter	HR [95% CI]	p-value
THYROTOXICOSIS	1.218 [1.12, 1.33]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.103

During the follow-up period (1.1.1998 — 31.12.2019), 6988 out of 42750 females with THYROTOXICOSIS died.

Males

Parameter	HR [95% CI]	p-value
THYROTOXICOSIS	1.423 [1.28, 1.58]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 2308 out of 10455 males with THYROTOXICOSIS died.

Mortality risk

Mortality risk for people of age

years, who have THYROTOXICOSIS.

N-year risk	Females	Males
1	0.107%	0.312%
5	0.702%	1.743%
10	1.649%	4.371%
15	3.151%	8.243%
20	5.552%	13.497%

Relationships between endpoints

↥

Index endpoint: THYROTOXICOSIS – Thyrotoxicosis

GWS hits: 44

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Thyrotoxicosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints